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The DNA damage response (DDR) recognises different types of DNA damage and 
initiates signalling pathways to bring about cell cycle arrest so the appropriate repair 
mechanisms can be activated, or to bring about cell death when the damage is 
unrepairable. DNA damage surveillance and repair pathways play an important role 
in protecting skin cells against the carcinogenic effects of ultraviolet radiation (UVR). 
In this research project, HaCaTs were used to investigate the direct and indirect 
effects of UVA irradiation on the DDR. Independent inhibition of ATM and ATR prior 
to irradiation with 50 kJ m-2 UVA caused cell survival to decrease in a dose-
dependent manner over that seen where HaCaTs were irradiated in the absence of 
inhibitor pre-treatment, suggesting the involvement of ATM and ATR in processing 
UVA-induced lesions. The same observation was not seen when the dosage was 
increased to 100 kJ m-2. Western blot and immunofluorescence studies found that 
H2AX activation peaked between 1 and 4h following irradiation with 100 kJ m-2 UVA. 
Chk2 phosphorylation peaked immediately following UVA irradiation. Inhibition of 
ATM prior to UVA exposure resulted in a temporal decoupling of H2AX and Chk2 
phosphorylation with peak H2AX activation occurring at a later timepoint whilst p-
Chk2 activation was unchanged, implying that UVA-induced Chk2 phosphorylation 
may not be entirely ATM-dependent. The UVA-induced bystander effect was also 
investigated. H2AX activation in bystander cells increased at 48h over that seen at 
24h when these cells were co-cultured with UVA-irradiated cells. A dose-dependent 
UVA-induced bystander response was observed following 1 week co-incubation as 
determined by clonogenic survival assays, which was not the case at 48h. These 
data suggest that the rate at which damage signals are released from irradiated cells 












Genomic integrity is constantly threatened by both exogenous sources, such as 
ultraviolet radiation, ionising radiation and toxins, and endogenous sources, which 
primarily consist of oxygen free radicals generated during mitochondrial respiration 
(Droge, 2002). The importance of maintaining such integrity is highlighted by the fact 
that the potential genomic alterations, such as DNA mutations or chromosomal 
rearrangements, are the primary causes of numerous diseases, which include both 
hereditary disorders and cancer (Sadikovic et al., 2008). Cancer is one of the leading 
causes of death worldwide and is the collective term used to describe a group of 
diseases characterised by abnormal, uncontrolled cell growth with the ability for such 
cells to metastasise and spread to other areas of the body. Thus, eukaryotic cells 
possess signalling networks that ensure the preservation of genomic integrity by 
detecting DNA damage and generating signals to bring about their repair. 
Collectively, these signalling networks make up the DNA damage response, which 
function to prevent deleterious mutations from occurring (Sulli et al., 2012). The aim 
of this literature review is to outline the DNA damage response in the context of 
damage that has been associated with skin cancer, one of the most common cancer 
types (Dubas and Ingraffea, 2013). It will discuss how ultraviolet radiation contributes 
to DNA damage, with emphasis on the understudied UVA wavelength region, and 
how it impacts the DNA damage response.  
 
I. Skin Cancer 
Skin cancer is the most common form of human malignancy with its global incidence 
steadily increasing for the past several decades, particularly amongst light-skinned 
populations (Dubas and Ingraffea, 2013). This steady increase has been attributed to 
a number of factors such as cheaper international travel, increasingly relaxed 
attitudes towards sunbathing, increased recreational use of sunbeds and ozone layer 
depletion (Wehner et al., 2014). All these factors share in common that they 
contribute towards increased exposure to ultraviolet radiation (UVR). The major 
source of UVR is solar radiation. Due to the earth’s atmosphere absorbing the UVC 
waveband and most of the UVB waveband, UVR reaching the earth’s surface 
consists of 90-95% UVA (315-400 nm) with the rest being UVB (280-315 nm). 
An increased desire to acquire tans for fashion and cosmetic purposes has 
contributed to the development of a large artificial tanning industry, particularly in 
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western countries where a significant proportion of residents have pale skin. Tanning 
beds are sources of both UVB and UVA. Radiation within the whole UV spectrum is 
associated with skin cancer and as a result tanning beds increase the risk of both 
nonmelanoma skin cancer and cutaneous malignant melanoma (Nilsen et al., 2016). 
Sunbeds can differ in the ratio of UVB to UVA they emit. In the past, the majority of 
sunbeds emitted less UVB and therefore more UVA, as UVB-rich sunbeds caused 
intermittent overexposures and risk of acute sunburns (WWW, WHO | Sunbeds). 
Solar radiation exposure has been found to result in a specific mutation fingerprint 
due to pyrimidine dimer generation in DNA, which was originally attributed to UVB. 
However, exposure to UVA alone generated the same mutation fingerprint in the skin 
of mice (Ikehata et al., 2008). Additionally, the same mutation spectra generated by 
UVB (C to T transition mutations following pyrimidine dimer generation) in the TP53 
gene in both the skin tumours of hairless mice and in humans were found to be 
induced by UVA (Runger and Kappes, 2008) (Agar et al., 2004). As such, in 2009 the 
full spectrum of UVR was categorised as carcinogenic to humans (El Ghissassi et al., 
2009). Consequently, many sunbed manufacturers are returning to producing 
sunbeds with a UVR output similar to natural sunlight (WWW, WHO | Sunbeds). 
However, a relatively recent study revealed that many sunbeds in the UK emit UVR 
levels that exceed British and European safety limits (Tierney et al., 2015, Tierney et 
al., 2013).  
Skin cancers are divided based on the skin cell type from which they originate, with 
strong epidemiological and molecular evidence between each type and UVR 
exposure. Non-melanoma skin cancers (NMSC), of which basal cell carcinoma 
(BCC) and squamous cell carcinoma (SCC) are the two most common subtypes, 
arise from keratinocytes. Together these NMSCs make up the majority of all skin 
cancers. Basal cell carcinomas, which originate from keratinocytes located within the 
basal layer of the epidermis, make up 80-85% of all NMSCs and are the most 
common form of malignancy amongst light-skinned populations. BCCs rarely invade 
other organs, whereas SCCs (5-10% of NMSCs), which arise from squamous 
epithelial cells within the skin’s epidermis, are more likely to metastasise and lead to 
death. Although mortality rates are low, NMSCs contribute towards physical and 
psychological consequences, particularly due to most NMSCs occurring on highly 
visible areas, such as the face and neck (Narayanan et al., 2010) (Lomas et al., 
2012).  
On the other hand, cutaneous malignant melanoma, which arises from melanocytes, 
account for the majority of skin cancer deaths, 55,000 deaths per year, despite 
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making up less than 10% of skin cancer cases (Ferlay et al., 2015). Cutaneous 
malignant melanoma incidence rates are highest within regions consisting of mainly 
light-skinned populations. Melanocytes are the melanin-producing cells, which are 
responsible for pigmentation and photoprotection. Two main types of melanin 
pigments are produced, brown/black eumelanin, which is photoprotective as it 
provides UVR attenuation, and red pheomelanin (Lo and Fisher, 2014). The 
importance of melanin in UVR protection is highlighted by the genetic disorder 
albinism, whereby patients have hypopigmentation of the skin, hair and eyes due to 
the loss of cutaneous melanin pigment production and as a result have a 
predisposition to the harmful effects of UVR such as photophobia, extreme sun 
sensitivity and increased risk of skin cancer development (Witkop, 1989). In contrast, 
melanin, particularly pheomelanin is also known to act as a photosensitiser that 
generates active oxygen species upon UV irradiation.  
 
II. Ultraviolet radiation 
The full spectrum of UVR can be divided into three wavebands: UVA (315-400 nm); 
UVB (280-315 nm) and UVC (200-280 nm) (Figure 1.1). Each waveband of UVR has 
been demonstrated as being able to contribute towards DNA damage. Solar radiation 
is the main source of UVR to which humans are exposed. UVC does not contribute to 
solar photocarcinogenesis as the earth’s atmosphere can completely absorb the 
waveband. The terrestrial UVR humans are exposed to vary slightly depending on 
geo-orbital and environmental factors, such as latitude, season, time of day and 
ozone layer thickness (Battie et al., 2014). The atmosphere can efficiently attenuate 
the majority of UVB, whilst all the UVA component of solar radiation is able to 
penetrate the atmosphere. Consequently, UVR reaching the earth’s surface consists 
of approximately 90-95% UVA with UVB making up the remainder, (El Ghissassi et 
al., 2009). Due to this, another factor thought to be contributing towards increased 
incidences or NMSC and CMM is ozone layer depletion. It is well established that 
various industrial halogenated chemicals including chlorofluorocarbons (CFCs) and 
methyl bromide, while inert at ambient temperatures on Earth’s surface, react with 
ozone in the extremely cold polar stratosphere, contributing towards its depletion, 
particularly in late winter and early spring (WWW, WHO | Climate change and human 
health – risks and responses. Summary). Due to this, it is estimated through the 
















population living at approximately 45 degrees north will have an approximate 5% 
excess of skin cancer incidence.   
UVA can penetrate glass, which UVB cannot. Consequently, high UVA exposure is 
possible within buildings and vehicles (Tewari et al., 2013). UVB is also less effective 
at penetrating and reaching the deeper layers of the skin than UVA. This was 
demonstrated by Tewari et al. (2013), where both types of UVB-induce DNA damage 
were shown to be attenuated with increasing skin depth, which was attributed to UVB 
absorbing chromophores in the skin. In contrast, they observed UVA to be less well 
absorbed by the upper layer of the epidermis with increasing amounts of DNA lesions 
generated by UVA seen with increasing skin depth. They suggest that this may occur 
due to UVA photons scattering in a forward or backward direction within the 
epidermis. Back scattering within the epidermis allows for increased opportunities for 
chromophores within the skin to absorb the photons whilst forward scattering 
Figure 1.1. Spectrum of ultraviolet radiation 
Ultraviolet radiation is a component of electromagnetic radiation with a wavelength of 100-400 nm. 
Ultraviolet radiation is split into three wavebands, UVC (200-280 nm), UVB (280-315 nm) and UVA 
(315-400nm). Ultraviolet radiation that reaches the earth’s surface consists of 90-95% UVA and 5-
10% UVB as all of the UVC component and 90-95% of the UVB component is absorbed by the 
earth’s atmosphere  
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increases the number of photons reaching the upper layers of the dermis (Tewari et 
al., 2013). It is well established that both UVA and UVB can produce different types 
of DNA damages, which can lead to the generation of harmful mutations and 
consequently photocarcinogenesis. However, the theoretical mechanisms by which 
they do so are thought to differ. 
Understanding the biological consequences of these UV-induced lesions requires an 
understanding of the generated photoproducts. Initial insights into UV-induced DNA 
damage came over 50 years ago, with the discovery that UVC can promote the 
dimerization of adjacent thymine residues, which was later shown to be a major DNA 
lesion generated upon UVB and solar irradiation (Cadet et al., 2012, Beukers and 
Berends, 1960). Since then, increased research has led to the understanding that 
UVB induces DNA damage via a direct mechanism. DNA bases are highly 
conjugated chromophores, with a peak absorbance of 260 nm. As a result, they can 
absorb within the UVR spectrum and can readily absorb UVB photons (280-315 nm) 
(Sutherland and Griffin, 1981). Photoexcitation by UVB can lead to the formation of 
covalent bonds between adjacent pyrimidines, of which there are two types, 
cyclobutane pyrimidine dimers (CPDs) and 6-4 pyrimidine-pyrimidone photoproducts 
(6-4PPs). These lesions significantly distort the structure of DNA, preventing the 
progression of replication and transcription as well as being mutagenic (Freeman et 
al., 1986, Sutherland et al., 1980).  
However, despite making up the majority of the terrestrial UVR we are exposed to, 
the mechanism by which UVA induces DNA damage is less well understood, with 
both direct and indirect mechanisms being proposed. UVA cannot be directly 
absorbed by DNA bases as the waveband falls outside the absorption spectrum for 
them. Despite this, there are numerous studies that have demonstrated that UVA is 
still able to generate CPDs (but not 6-4PPs) (Tewari et al., 2013, Freeman et al., 
1987). Consequently, it is thought that UVA-induced CPD formation occurs via an 
indirect pathway with macromolecules other than DNA functioning as UVA 
photosensitisers. It is theorised that this indirect mechanism involves the formation of 
reactive oxygen species (ROS), which can damage numerous cellular biomolecules, 
including DNA bases through the process of oxidation. This theory explains why UVA 
exposure leads to the generation of oxidised bases such as 8-oxoguanine, the most 
common type of DNA lesion resulting from base oxidation by ROS (Kielbassa et al., 
1997, Kvam and Tyrrell, 1997). However, recent studies have demonstrated the 
ability of UVA to generate CPDs in isolated, purified genomic DNA, implying that 
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UVA also has the potential to generate DNA damage directly (Jiang et al., 2009, 
Mouret et al., 2006a).  
 
III. Pyrimidine Dimers 
As mentioned previously, both UVA and UVB are able to induce DNA damage by 
generating pyrimidine dimer photoproducts, of which there are two main species 
cyclobutane pyrimidine dimers and 6-4 pyrimidine-pyrimidone photoproducts (Figure 
1.2). CPDs occur at a higher frequency than 6-4PPs, as demonstrated by 
experiments involving transfected mouse cell lines or transgenic mice that 
ubiquitously express CPD-photolyase, 6-4PP-photolyase, or both (Jans et al., 2005, 
You et al., 2001). Photolyases are repair enzymes that bind to CPDs or 6-4PPs in a 
lesion-dependent manner and rapidly repair the damage by splitting the dimers back 
to undamaged bases in a light-dependent manner. Placental mammals have 
undergone an evolutionary loss of these repair enzymes and therefore must rely on 
the nucleotide excision repair pathway to repair UV-induced lesions. Both studies 
were able to use these photolyase enzymes to identify CPDs as the main pyrimidine 
dimer photoproduct generated following UV exposure. One explanation for why this 
may be the case is that 6-4PPs are efficiently removed and repaired by NER (Sinha 
and Hader, 2002). 6-4PPs can be photoisomerised by wavelengths longer than 290 
nm to form related Dewar isomers, which are highly mutagenic and poorly repaired 
(Lee et al., 2000). Both CPDs and 6-4PPs are formed from the covalent cross-linking 
of adjacent pyrimidine bases. 
CPDs are generated in a [2+2] photocycloaddition reaction between the C5-C6 
double bonds of adjacent pyrimidine bases, leading to the formation of a cyclobutane 
ring (Schreier et al., 2007). Sequence context has been demonstrated to be a factor 
impacting the distribution of UVB-induced CPDs, with TT dimers occurring most 
frequently and CC occurring least frequently (Douki and Cadet, 2001). Appropriate 
orientations of the reacting double bonds are required for the photocycloaddition 
reaction to occur. Usually, such as in reactions between two ethylene molecules, the 
reaction yields multiple stereoisomers. However, due to DNA backbone constraints, 
only a single CPD isomer is formed following exposure to UVR, in both naked and 
cellular DNA (Schreier et al., 2007). 6-4PPs are also generated via [2+2] 
cycloaddition reactions, however, these lesions are generated via the reaction 
occurring between the C5-C6 double bond of the 5’-end pyrimidine base and the C4 




















The mutation signature generated following UV-induced pyrimidine dimer formation is 
characterised by cytosine (C) to thymine (T) transitions, and although rare, CC to TT 
tandem base substitutions can also occur (Setlow, 1974). These substitutions are 
generated following the hydrolytic deamination of cytosine- and 5-methylcytosine-
containing lesions to produce uracil and thymidine residues, respectively. 
Consequently, two adjacent cytosine bases are considered mutation hotspots for 
UVA and UVB irradiation (Ravanat et al., 2001b). The importance of this mutation 
signature in contributing towards skin cancer is highlighted by the TP53 gene, 
whereby C to T transitions represent approximately 35% of p53 mutations, localised 
to several mutation hotspots  (Tornaletti and Pfeifer, 1995). 
Whilst CPDs and 6-4PPs have been well documented as being DNA base 
photoproducts of UVB irradiation, UVA has also been established as being able to 
form pyrimidine dimers. The ability of UVA to generate CPDs was initially 
Figure 1.2. Pyrimidine dimer formation 
UVA and UVB radiation are both able to induce DNA damage by generating pyrimidine dimer 
photoproducts, which consist of two main species, cyclobutane pyrimidine dimers (CPDs) and 6-4 
pyrimidine-pyrimidone photoproducts (6-4 PPs). CPDs are generated in a [2+2] photocycloaddition 
reaction between the C5-C6 double bonds of adjacent pyrimidine bases, generating a cyclobutane 
ring. 6-4PPs are generated via [2+2] cycloaddition reactions between the C5-C6 double bond of 
the 5’end pyrimidine base and the C4 carbonyl group of the 3’-end pyrimidine base. The figure 
represents the formation of thymine photodimers following photocycloaddition reactions between 
adjacent thymine residues.  
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demonstrated in bacteria (Tyrrell, 1973). Following this, as well as being able to 
generate oxidative lesions, CPDs were detected in UVA-irradiated human skin, 
although it was estimated that UVA was 104-105-fold less effective than UVB at 
generating CPDs (Freeman et al., 1989, Burren et al., 1998). Interestingly, despite 
being less effective at generating CPDs, there is evidence to suggest that pyrimidine 
dimers generated by UVA are more mutagenic than those induced by UVB. It was 
hypothesised that the increased mutation rate seen for UVA-induced pyrimidine 
dimers is due to the mechanism by which the cells process the DNA damage 
(Runger et al., 2012). Cell cycle regulation, DNA repair and apoptosis induction in 
primary human fibroblasts following equimutagenic doses of UVA and UVB-
irradiation were compared. It was found that cell cycle arrest regulated, in part, by the 
activation of p53, was prolonged and more prominent in UVB-irradiated cells than 
UVA. 
UVA cannot be directly absorbed by DNA bases and as a result, it was generally 
believed that its mutagenic effect does not occur through dipyrimidine photoproduct 
formation. For this reason, it was previously believed that UVA-induced damage was 
ROS-dependent (Ravanat et al., 2001b). However, two studies in 1999 demonstrated 
that UVA exposure can directly lead to the generation of CPDs (Douki et al., 1999, 
Kuluncsics et al., 1999). Despite being less effective than UVB, CPDs have since 
been demonstrated as being the predominant lesions generated by UVA in rodent 
skin cells, cultured mammalian cells and in whole human skin (Courdavault et al., 
2004, Douki et al., 2003, Mouret et al., 2006b). Comparing the ratio of UVA-induced 
CPDs to 8-oxoguanine, the most common DNA lesion generated from oxidative 
damage, revealed CPD levels to be approximately 5-fold higher, with slight variation 
depending on the cell type (Mouret et al., 2012). Interestingly, a CPD:8-oxoguanine 
ratio of 1.4 was observed in melanocytes, indicating that this cell type possesses a 
mechanism that contributes towards increased oxidative stress. Despite this, the 
possibility that the decreased ratio arose due to decreased generation of CPDs 
needs to be considered. When comparing the levels of CPDs and 6-4PPs in the 
epidermis and dermis in skin biopsies, which had been taken immediately following 
irradiation with equivalent doses of UVA or UVB, not only was it demonstrated that 
UVB-induced lesions were attenuated with increasing skin depth but also that UVA-
induced CPD levels were highest at the basal layers of the epidermis (Tewari et al., 
2013, Tewari et al., 2012). These studies, as with the majority of studies looking at 
the ability of UVA to generate 6-4PPs suggest that UVA is unable to generate such 
lesions (Mouret et al., 2010). One suggestion for why this occurs is that these lesions 
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are repaired very efficiently, even during the irradiation period. Support for this was 
provided when 6-4PPs were observed in cell lines deficient in components for 
nucleotide excision repair (Cortat et al., 2013). Interestingly, despite being unable to 
generate 6-4PPs, UVA has been shown to be more efficient at inducing the photo-
isomerisation of these to Dewar isomers (Courdavault et al., 2005). 
Regardless of whether they were generated from UVA or UVB irradiation, pyrimidine 
dimers introduce distortions into the structure of DNA that prevent replication by 
preventing replicative DNA polymerases from passing them (Horsfall and Lawrence, 
1994). These lesions are recognised by components of the nucleotide excision repair 
pathway (NER), a pathway with two mechanisms for the detection of DNA damage; 
transcription coupled repair, which detects lesions in transcribed regions of the 
genome and global genome repair, which detects lesions across the entire genome 
(Batty and Wood, 2000). The importance of global genome NER in the repair of 
UVR-induced damage is highlighted by Cockayne’s syndrome where patients 
possess mutations in transcription coupled repair genes. Patients with this disorder 
possess neurological abnormalities but do not have a predisposition to skin cancer 
development, as patients still possess functioning ggNER (Murray et al., 2016). 
NER is fairly efficient at removing pyrimidine dimers and similar lesions before they 
are replicated, however, in the event that NER is unable to complete the repair, cells 
possess other mechanisms to help prevent mutagenic outcomes. One such 
mechanism is known as translesion DNA synthesis (TLS), whereby specialised DNA 
polymerases known as TLS polymerases are able to use lesions as templates in 
order to bypass DNA lesions by incorporating nucleotides opposite the lesion 
(Waters et al., 2009). It is proposed that TLS polymerases carry out their function by 
ignoring conventional Watson-Crick base pairing rules, which would be expected to 
be error-prone. However, the TLS polymerase specific for CPDs, DNA polymerase 
(Polη)is able to prevent the generation of mutations with relative efficiency, as 
seen with the process being non-mutagenic for T-T dimers, which make up the 
majority of UVA- and UVB-induced pyrimidine dimers (Masutani et al., 2000). 
However, in the event that cytosine residues within dimers are deaminated to uracil 
residues, the mechanism of action for Polη means C to T and CC to TT transitions, 
which make up the UV signature for both UVA and UVB, are possible outcomes 
(Biertumpfel et al., 2010, Ikehata and Ono, 2011). 
For a long time it had been suggested that the pyrimidine dimer signature produced 
following UVA irradiation was photosensitiser mediated. However, recent studies 
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examining the damage spectra generated by UVA on isolated DNA revealed that 
CPDs are generated with similar distributions to those observed in keratinocytes. The 
generation of CPDs in the absence of photosensitisers suggests that UVA produces 
these lesions directly. Although this is a large step forward in resolving the 
controversy regarding the origin of UVA-induced CPDs, the exact mechanism by 
which is does so remains to be elucidated (Jiang et al., 2009). Potential insight was 
provided in 2010 when the formation of all four possible CPD bipyrimidine dimer 
products were compared in the context of UVA irradiated cells, isolated genomic 
DNA and an oligonucleotide duplex sequence (dA(20):dT(20)) (Mouret et al., 2010). 
The relative frequencies of the lesions to each other was similar in the three types of 
samples, providing support for UVA possessing a direct photochemical mechanism. 
They suggested that, although the individual bases are unable to absorb UVA 
directly, that the double-stranded structure of DNA increases the capacity for the 
bases to absorb UVA photons. Whether or not ssDNA sequences produce similar 
mutation spectra needs to be considered.  
It is important to note that whilst the majority of lesions within DNA generated 
following UVA exposure are CPDs and that there is emerging evidence for this being 
mediated via a direct mechanism, one cannot rule out the role of photosensitisers 
and other types of DNA damage in UVA-induced mutagenesis. This has been 
demonstrated by the fact that by lowering the dose of UVA caused increased 
cytotoxicity, which was attributed to increased DNA damage via increase ROS-
mediated oxidation and lipid peroxidation (Shorrocks et al., 2008). The importance of 
understanding the role of various dose rates and how they contribute towards UVA-
induced DNA damage has real world importance as UVA dosages vary considerably 
with geographical location, time of day and the use of different sunscreens. 
Understanding the indirect mechanism by which photosensitisers contribute towards 
UVA-induced mutagenesis is therefore also required alongside knowledge of UVA’s 
direct mechanisms of action. 
 
IV. Oxidative DNA base damage 
As mentioned earlier, although there are implications for DNA duplexes absorbing 
UVA directly, the UVA waveband of UVR falls outside of the absorption spectrum for 
individual DNA bases. UVA however can be directly absorbed by endogenous 
photosensitisers such as riboflavin, flavins, porphyrins and also melanin (Cadet et al., 
2015). Absorption of UVA photons by these cellular biomolecules leads to the 
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generation of reactive oxygen species (ROS), which include hydrogen peroxide, 
hydroxyl radicals and singlet oxygen. The photoexcitation of these molecules occurs 
via one of two reactions, known simply as type 1 and type 2 photosensitisation 
reactions (Figure 1.3). The ROS generated via these reactions are the molecules 
responsible for generating DNA damage.  
In the type 1 photoexcitation reaction, the excited photosensitiser reacts directly with 
a target molecule in its vicinity (Cadet et al., 2015). This results in electron 
abstraction from the molecule, producing a pair of charged radicals. The anion 
photosensitiser radicals are oxidised back to their neutral state by reaction with 
oxygen. The cation radical, within an aqueous environment, can then undergo either 
deprotonation and/or hydration reactions. In either case, neutral radicals are 
generated, which can go on to react with molecular oxygen or O2-, generating peroxyl 
radicals, intermediates that can yield final oxidation products through additional 
reactions.  
The type 2 photoexcitation reaction, on the other hand, involves the energy transfer 
from the excited photosensitiser to molecular oxygen. The excited oxygen (1O2) can 
react according to three main mechanisms, of which the ene-reaction that yields 
hydroperoxides is the most important in terms of generating DNA damage (Greer, 
2006). A side reaction of this process involves charge transfer with oxygen, 
generating O2-. Dismutation of two superoxide ions catalysed by superoxide 
dismutase generates hydrogen peroxide. H2O2 oxidises ferric ions to yield hydroxyl 
radicals (Finkel and Holbrook, 2000). Both types of reaction are therefore similar in 
that they result in the generation of ROS, particularly singlet oxygen (1O2) and 
hydroxyl radicals (•OH), which can damage a range of cellular biomolecules, such as 
DNA.  
The exact nature of the photosensitisers involved in UVA-mediated oxidative DNA 
damage is unclear, with flavins, porphyrins and even melanin proposed as being 
endogenous photosensitisers for UVA (Wondrak et al., 2006). The differences in the 
properties of the excited states of the different photosensitisers means that there is 
likely more than one potential pathway for generating oxidative damage. ROS can 
generate a number of different DNA lesions. ROS-mediated oxidation can occur at all 
four bases, but occurs most frequently at guanine bases, which are oxidised at high 
rates due to their higher oxidation rates, with the most frequently generated DNA 











8-oxoG is well established as being a product of UVA irradiation, as demonstrated in 
cultured cells and in skin (Mouret et al., 2006b, Rosen et al., 1996). The generation 
of 8-oxoG via 1O2 begins with the conversion of guanine to 4,8-endoperoxide via a 
1O2-mediated Diels Alder [4+2] photocycloaddition reaction. The resulting 
intermediate product is able to rearrange within dsDNA, forming 8-
hydroxyperoxyguanine, which is then further reduced to 8-oxoG (Sheu et al., 2002, 
Ravanat et al., 2001a). •OH, in contrast to 1O2 does not specifically target DNA 
bases, but reacts with all components of DNA (Cadet et al., 1999). When •OH reacts 
with purines, a C8-hydroxylated radical is generated, which then gives rise to 8-oxoG 
along with degradation products of adenine (Cadet et al., 2012). •OH can also react 
with pyrimidines at the C5-C6 double bond to generate oxidative lesions of adenine 
and thymine. 
Although CPDs are the predominant lesion generated by UVA exposure, the 
importance of oxidative damage still needs to be acknowledged when considering 
the UVA-mutagenic signature, particularly within melanocytes where the ratio of 
CPDs to 8-oxoG lesions is much smaller when compared to other cells types (Mouret 
et al., 2012). Analysis of the mutagenic potential of 8-oxoG lesions demonstrated that 
the predominant mutation is a G:C to T:A transversion (Yasui et al., 2014). There 
Figure 1.3 Type I and type II photosensitisation reactions 
In photosensitisation reactions, a sensitiser absorbs a photon and becomes excited. Endogenous 
photosensitisers include cytochromes, flavins, riboflavins, porphyrins and melanin. Absorption of 
photons by these photosensitisers leads to the generation of reactive oxygen species (ROS), such 
as hydrogen peroxide, hydroxyl radicals and singlet oxygen. In the type I reaction, the excited 
photosensitiser reacts with a target molecule in its vicinity whilst in the type II reaction, energy is 
transferred from the excited photosensitiser to molecular oxygen. Both types of reaction result in 




have been controversies in the past in regards to the UVA mutagenic signature. A 
number of groups have studied the pattern of mutations induced by UVA in cultured 
cells, but there have been some differences between the reported mutation spectra 
(Besaratinia et al., 2004, Robert et al., 1996). One of the mutations observed most 
frequently was the otherwise rare T to G transversion that was determined to be too 
unique as to be rarely induced by other conditions within the studies. Furthermore, 
this transversion was mainly found following exposure of Chinese hamster ovary 
cells to UVA but not to UVB, hence this mutation was designated as the UVA 
fingerprint (Huang et al., 2009). The same fingerprint was detected in a study 
involving human skin tumours, with particular bias towards the basal epidermal layer 
and the dermis (Agar et al., 2004). This raises questions in regards to how 8-oxoG 
contributes towards UVA-induced mutagenesis as this oxidation product is 
understood to induce G to T mutations, which are rarely observed following UVA 
exposure (Rochette et al., 2003, Sage et al., 1996). 
Oxidation of DNA bases to generate lesions such as 8-oxoG is not unique to UVR 
and other forms of radiation. ROS are constantly being generated endogenously as 
by-products of oxidative metabolism within the mitochondria and as a result, DNA 
bases are constantly under pressure of oxidation. Consequently, cells have evolved 
effective defences against oxidative damage through the process of base excision 
repair (BER), initiated when DNA glycosylases recognise and remove the damaged 
bases. Due to the number of base alterations possible through oxidation and other 
processes such as deamination and alkylation, there are multiple DNA glycosylases 
available, each possessing selective binding sites specific to particular types of base 
modifications (Kim and Wilson, 2012). The DNA glycosylase responsible for the 
recognition and removal of 8-oxoG is OGG1. Indirect indication for the UVA-induced 
oxidative stress came when it was demonstrated through confocal microscopy that 
hOGG1 was recruited to the nuclear matrix from a nucleoplasmic localisation 
following UVA irradiation (Campalans et al., 2007). Furthermore, two years prior to 
this, an investigation into how multiple yeast mutants were affected by UVA exposure 
was conducted. Here it was shown that all of the major DNA damage repair 
pathways, of which BER is included, were able to protect yeast from the lethal action 
of UVA. OGG1 DNA glycosylase was shown to be very efficient at preventing UVA-
induced mutagenesis (Kozmin et al., 2005). Interestingly, the use of anti-hOGG1 
immunohistochemical staining of frozen sections from human skin found that hOGG1 
was expressed at highest levels in the upper region of the epidermis, with lowest 
levels seen in the basal cells (Javeri et al., 2008). This has implications in 
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carcinogenesis as basal cell carcinoma arises from these proliferating basal cells. 
The lower levels of the DNA repair enzyme OGG1 in these cells may account for the 
accumulation of UVA-induced oxidative damage and therefore increased 
mutagenesis (Halliday et al., 2011).  
As well as having implications in NMSC carcinogenesis, oxidative damage also has 
implications in melanoma skin cancer. Melanocytes are located in the stratum basale 
of the skin’s epidermis and therefore have lower levels of OGG1 than cells located in 
the upper layers of the epidermis (Javeri et al., 2008). Similar repair rates for 
oxidative modifications of purine bases were observed in human skin fibroblasts and 
melanoma cells under normal conditions and following UVA irradiation. However, the 
repair of these modifications was severely compromised in glutathione-depleted cells 
following UVA irradiation for both cell types, suggesting that the base excision repair 
of oxidative purine modifications is vulnerable to oxidative stress, which is not the 
case for pyrimidine dimers (Eiberger et al., 2008). Also, whilst CPDs were found to 
be the most frequently generated lesion by UVA irradiation for keratinocytes, 8-oxoG 
has been shown to be more readily induced by UVA exposure in melanocytes 
compared to keratinocytes (Mouret et al., 2012). This is consistent with the 
suggestion that a factor affecting the distribution of UVA-induced lesions is cell type-
specific. Evidence for melanocytes being more susceptible than other cell types for 
UVA-induced oxidative damage has been provided in both cultured cells and in 
pigmented mice (Noonan et al., 2012, Wang et al., 2010). The possible importance of 
UVA-induced oxidative damage is supported by evidence that the second most 
common type of mutation seen in melanomas are G to T transversions, implying that 
8-oxoG has a large role in melanomagenesis (Pleasance et al., 2010). The increased 
frequency of lesions that occur via photosensitisation reactions within melanocytes 
suggests a role for melanin pigments in the generation of these lesions. 
Initial suggestions for the role of melanin as a photosensitiser in the induction of DNA 
damage came in 1993. Here, the induction of malignant melanoma was investigated 
in heavily pigmented hybrids of the genus Xiphophorus, which are highly sensitive to 
melanoma induction following single UV exposures. It was found that melanoma 
induction had particular sensitivity at 365, 405 and 436 nm, wavelengths that are not 
directly absorbed by DNA, and correspond in part with the UVA waveband of UVR. It 
was interpreted that photons of these wavelengths were absorbed by melanin and 
that melanoma induction is mediated by wavelengths within the UVA region (Setlow 
et al., 1993). At the time, the ability to apply these findings to human melanoma skin 
cancers was questionable as whether or not this fish model was suitable for human 
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melanomas was not fully understood. Re-evaluation of the methodology and model 
used has since discredited the findings from this study, with it now being accepted 
that only UVB is able to induce melanoma formation in this particular model (Mitchell 
et al., 2010). However, since then, a number of studies have been conducted, 
investigating the role of melanin as a photosensitiser in UVA-induced mutagenesis.  
The two types of melanin, eumelanin and pheomelanin are derived from a common 
precursor, dopaquinone (Wondrak et al., 2006). Most melanin pigments in skin 
tissues are mixtures of eumelanin and pheomelanin with melanocytes of light-
skinned individuals primarily producing pheomelanin. Pheomelanin has a limited 
capacity to absorb UVR and the limited photoprotection provided by pheomelanin 
explains why the incidence of skin cancer is increased amongst light-skinned 
populations. Noonan et al. (2012) studied melanoma induction by UVA and UVB in 
mice, whose melanin consisted of >90% eumelanin. They found that UVA melanoma 
induction was melanin dependent whilst UVB melanoma induction occurred in a 
pigment-independent manner. A suggested mechanism for how melanin functions as 
a photosensitiser in melanomagenesis came in 2015. Here it was shown that CPDs, 
that are typically generated picoseconds following UV exposure, were still being 
generated 3 hours following UVA irradiation within melanocytes (Premi et al., 2015). 
These so-called “dark CPDs” constitute the majority of CPDs seen in melanocytes 
following UV exposure. UVR is known to upregulate the nitric oxide synthase iNOS, 
NADPH oxidase (NOX) and enzymes involved in melanin synthesis, resulting in 
sustained generation of nitric oxide (NO•) and superoxide (•O2-) radicals. UVA 
exposure results in increased generation of these radicals causing increased 
peroxynitrite (ONOO-) generation. The increased levels of ONOO- causes melanin 
degradation, producing fragments that are able to pass into the nucleus. Electrons 
within these fragments can be excited to a quantum triplet state, which has the same 
energy as UV photons and can induce CPDs by energy transfer to DNA. These 
studies are significant as they indicate melanin to not only play protective roles 
against skin carcinogenesis but also in promoting carcinogenesis.  
 
V. Double strand breaks 
The ability for UVR to generate base modifications has been well established, 
however, it is also important to consider the capacity for UVR to induce both single-
strand (SSB) and double-strand breaks (DSBs). The ability for UVR to generate 
single-strand breaks as minor classes of DNA damage has been demonstrated in a 
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number of cases, including experiments involving exposure of human keratinocytes 
to UVA (Wischermann et al., 2008). SSBs are repaired efficiently and do not 
significantly contribute to mutation formation, whilst DSBs are highly mutagenic and 
carcinogenic as they induce genomic instability by promoting the generation of 
deletions and insertions (Rizzo et al., 2011). UVB has been established as being able 
to induce the formation of DSBs with suggestions that it occurs following the collapse 
of replication forks at unrepaired CPDs, which are readily generated by UVB (Garinis 
et al., 2005). The ability of UVA to induce DSB formation however is debated.  
DSBs can be repaired through either homologous recombination or non-homologous 
end joining (NHEJ) with activation of the former occurring through the Fanconi 
anaemia (FA)/BRCA pathway. In investigating UVA-induced DSB formation, Rizzo et 
al (2011) studied the activation of this pathway in primary skin fibroblasts following 
exposure to different doses of UVA at various times following irradiation. They found 
that UVA was unable to activate this pathway, unlike ionising radiation and UVB, 
suggesting that UVA does not induce DSBs. They supported this with evidence that 
UVA did not induce DSBs through investigation of H2AX nuclear foci formation, 
which is considered to be a biomarker of DSB formation. Despite this however, there 
is an abundance of evidence to suggest that UVA can induce DSBs, although the 
exact mechanism by which this occurs remains to be elucidated.  
Contrary to the findings by Rizzo et al (2011), a number of other studies have found 
UVA irradiation is able to induce H2AX formation. Whilst Rizzo et al. were unable to 
detect H2AX formation at doses of 400 kJ m-2, a dose-dependent increase in H2AX 
generation was observed up to 160 kJ m-2 in JB6 cells (Lu et al., 2006). Determining 
whether the H2AX nuclear foci formed are due to UVA-induced DSB formation or 
not is difficult to determine, as H2AX can also be activated via different forms of 
damage via the DNA damage response or independent of DNA damage, such as 
through heat shock. Additional evidence for DSB generation by UVA exposure came 
when components of both the error-prone NHEJ and homologous recombination 
were investigated following UVA exposure. Components exclusive to the individual 
pathways and components involved in both were compared. XRCC4, DNA-PK and 
Ku70 were used as representative of NHEJ, Rad51 and Rad52 were used for 
homologous recombination and Mre11 and Rad50, which are involved in the 
detection of DSBs, were used as representatives of both pathways. It was found that 
in G2 cells, in which both repair pathways are active, the repair pathways cooperate 
to repair the same DSBs following UVA exposure (Rapp and Greulich, 2004). This is 
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supported by evidence that cell lines deficient in DSB repair pathways were sensitive 
to UVA and formed increased chromosome damage following DSB formation (Fell et 
al., 2002).  
Although providing evidence that UVA exposure can lead to the formation of DSBs, 
these studies do not provide any indication regarding the exact mechanism by which 
they do so. A recent paper proposed that UVA-induced DSBs result from the repair of 
clustered oxidative DNA damages (Greinert et al., 2012). It has been demonstrated 
for other types of radiation and chemical toxins that DNA lesions generated by 
oxidising agents are converted into DSBs during their repair, whereby both DNA 
strands are incised simultaneously in close proximity (Gulston et al., 2004). UVA 
photons possess insufficient energy to induce covalent bond breakages directly and 
so DSBs must be generated by UVA indirectly. Greinert et al. (2012) detected DSBs 
immediately following UVA exposure through the use of neutral Comet assays and 
H2AX formation. The use of the antioxidant Naringin prior to irradiation prevented 
DSB formation, indicating that ROS, which as previously mentioned are readily 
generated by UVA, are involved in DSB formation. Consequently, it was interpreted 
that the mechanism for UVA-induced DSB formation is similar to that of other types 
of radiation in that it occurs via the clustering of oxidative lesions followed by their 
repair.  
 
VI. The bystander effect 
The radiation-induced bystander effect, which was first discovered in 1954, refers to 
the phenomenon whereby nonirradiated cells exhibit the characteristics of irradiated 
cells due to signals received from nearby irradiated cells (Parsons et al., 1954). The 
characteristic events that occur in these nonirradiated cells appear mainly as cell-
damaging effects such as apoptosis induction, cytogenic damage and activation of 
the DNA damage response and repair pathways. The bystander effect has been well 
established for ionising radiation (Rzeszowska-Wolny et al., 2009, Prise et al., 2003). 
UVA and UVB have also been found to be able to induce bystander effects, but the 
exact mechanism by which they do so remains to be elucidated (Dahle et al., 2005). 
For example, does the bystander effect occur by signals passing from an irradiated 
cell to an unirradiated cell via intracellular junctions, such as gap junctions, or does it 
occur through paracrine signalling?  
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In one study, human keratinocytes and fibroblasts were exposed to UVA or UVB 
irradiation and were co-cultured with unirradiated cells, with the differentially treated 
populations separated by a medium-permeable insert, meaning the cells were not in 
direct contact with each other (Whiteside and McMillan, 2009). Here, they observed 
that irradiation with 100 kJ m-2 UVA was able to induce a bystander effect as 
determined by reduced clonogenic survival of the unirradiated cells, whilst similarly 
toxic doses up to 0.4 kJ m-2 UVB did not have the same outcome. Using a similar co-
culture method with human dermal fibroblasts, a study using considerably increased 
doses of UVB (up to 10 kJ m-2) and decreased doses of UVA (up to 20 kJ m-2) found 
that both UVB and UVA caused a dose-dependent decrease in survival and increase 
in apoptosis in the bystander cells (Widel et al., 2014). The study also investigated 
the roles of ROS and interleukins 6 and 8 (IL-6 and IL-8). Increased levels of ROS 
and IL-6 were detected within the bystander cells and within the media of the 
irradiated cells, implicating a role for these in generating the bystander effect 
following UVB or UVA irradiation. Further evidence for the role of ROS in the UVR-
induced bystander effect came with studies involving melanocytes. Here, although 
melanocytes appeared to be more resistant that keratinocytes or fibroblasts to the 
direct effects of UVA, melanocytes were found to be more susceptible to the 
bystander effect following co-culturing with UVA-irradiated keratinocytes or 
fibroblasts (Redmond et al., 2014).  
It would be expected that the ROS involved in the UVA-induced bystander effect are 
generated from type 1 and type 2 photosensitisation reactions, however, there is also 
some evidence to suggest that the UVA excitation of dermal extracellular matrix 
protein chromophores could possible give rise to ROS that participate in generating 
the bystander effect (Wondrak et al., 2006). The most abundant potential target for 
UV photons in human skin are chromophores associated with skin structural proteins, 
which include keratin, collagen and elastin. An example of the potential role of these 
in ROS generation was seen when collagen and elastin were found to be active 
photosensitisers for UV-driven generation of H2O2 (Wondrak et al., 2003).  
 
VII. Skin cancer mutational signatures 
All cancers possess somatic mutations, of which a certain subset, known as driver 
mutations are responsible for inducing cancer development by inducing uncontrolled 
cell growth. Additional information can be provided about how specific cancers arise 
by analysing the spectrum of mutations that occur. In the context of skin cancer, 
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sufficient information is available in regards to the mechanisms by which the 
components of UVR contribute to the generation of different DNA damage lesions. 
However, the damage needs to be understood in the context of UVR carcinogenesis 
by examining how the generated lesions affect specific genes and the outcomes this 
has on carcinogenesis. Catalogues of somatic mutations provide great insight into 
the forces that shape the particular cancer’s genome. For example, Pleasance et al. 
(2010) used next generation sequencing to sequence the genomes of a malignant 
melanoma and a lymphoblastoid cell line from the same person, providing a 
catalogue of somatic mutations from an individual cancer. The dominant mutational 
signature found, C to T transition, reflected DNA damage that arises following UVR 
exposure.  
There are a number of genes, usually either proto-oncogenes or tumour suppressor 
genes, which are frequently mutated across the many different types of cancer. One 
of the most frequently mutated genes in human cancer is TP53 (Olivier et al., 2010). 
CPDs generated by both UVB and UVA account for the major UV signature mutation 
of C to T transitions or CC to TT tandem mutations, which account for approximately 
35% of p53 mutations, localised to several mutational hotspots (Tornaletti and 
Pfeifer, 1995). These mutations have been found in the TP53 gene in both BCCs and 
SCCs (Rady et al., 1992, Brash et al., 1991). Early studies suggested that more than 
90% of SCCs and more than 50% of BCCs possessed TP53 mutations, however, it is 
now thought that the frequency is approximately 50% of all skin cancer but that the 
frequency is over 90% in skin cancers of xeroderma pigmentosum patients 
(Boukamp, 2005).  
BCCs have also been shown to contain UVR-induced mutations in PTCH, which is a 
member of the hedgehog-patched-smoothened pathway, which is deregulated in 
more than 70% of BCCs (Brash, 2015). The PTCH tumour suppressor gene was 
discovered following studies looking at the autosomal dominant disorder nevoid basal 
cell carcinoma (NBCC) syndrome, which is characterised by multiple BCCs at an 
early age (Kimonis et al., 1997). Additionally, novel mutations in the promoter region 
of the telomerase reverse transcriptase gene (TERT), which had previously been 
observed in up to 71% of cutaneous malignant melanoma cases were also 
demonstrated to occur in 50-78% of NMSC cases, following C to T or CC to TT 
mutations as a result of UVR exposure (Griewank et al., 2013). These mutations 
result in increased TERT expression due to an increased number of ETS/TCF 
transcription factor binding sites. Telomerase is a ribonucleoprotein that is 
responsible for adding telomeric sequences, TTAGGG hexamers, to the ends of 
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chromosomes in order to maintain telomeres (Horn et al., 2013). Telomeres shorten 
progressively over multiple cell generations and eventually lose the ability to protect 
the ends of chromosomes from end-to-end fusions which threaten cell viability. The 
increased expression of TERT serves to maintain telomere lengths and therefore 
contributes to one of the hallmarks of cancer by enabling replicative immortality 
(Hanahan and Weinberg, 2011).  
Melanomas, as well as NMSC, show preferential mutational signatures towards 
particular driving mutations. The best-studied and most common mutation that occurs 
in melanomas is the oncogenic mutation of BRAF, occurring in approximately 44% of 
melanomas (Davies et al., 2002). The majority of mutations are V600E point 
mutations that arise following a T to A transversion. BRAF encodes a 
serine/threonine kinase downstream of Ras in the RAS/RAF/MAPK pathway 
(Thomas et al., 2004). It has been demonstrated in vitro and in vivo that this point 
mutation alone results in senescence and in order to induce tumour formation, 
additional genetic alterations are required (Patton et al., 2005). The CDKN2A locus, 
at which two distinct tumour suppressors, p16INK4a and p14ARF are encoded by 
alternative reading frames, has also been shown to be frequently mutated in 
melanoma (Sharpless and Chin, 2003). Numerous studied have linked the loss of 
p16INK4a and melanoma and now a recent study has implicated the loss of p14ARF with 
assisting the V600E point mutated BRAF in inducing melanomagenesis (Luo et al., 
2013). The group proposed that this occurred as the two mutations synergise to 
inhibit NER via epigenetic repression of XPC. Another study has also suggested that 
BRAFV600E can contribute to melanomagenesis via cooperation with mutated TP53 
(Viros et al., 2014).  
In addition to BRAF mutations, oncogenic RAS mutations comprise another subset of 
mutations that are frequently present in cancer. RAS, a small GTP-binding protein, 
activates a number of effector proteins such as phosphoinositide 3-kinase (PI3K), 
RAF protein kinases in order to regulate signalling pathways responsible for 
controlling proliferation, senescence and cell survival. Mammals possess three RAS 
genes, HRAS, KRAS and NRAS. The proteins these encode serve overlapping but 
non-identical functions and promote oncogenesis once mutationally activated at 
codon 12, 13 or 61 (Prior et al., 2012). Despite the high degree of similarity among 
isoforms, each isoform displays a preference towards particular cancer types. NRAS 
is second most frequently mutated gene in melanoma, occurring in approximately 
18% of melanoma cases, with more than 80% of mutations occurring at glutamine 61 
(Pedersen et al., 2014). In contrast, KRAS and HRAS account for 2% and 1% of 
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melanoma cases, respectively. As with BRAF, multiple studies employing transgenic 
mouse models have shown that oncogenic NRAS can only induce melanomagenesis 
if tumour suppressor genes were also deleted.  
The requirement of additional mutations in tumour suppressor genes and proto-
oncogenes in order for BRAF and NRAS to induce melanomagenesis demonstrates 
the importance of additional driver mutations in melanoma. As a result, the 
advancement of genome sequencing technologies to identify new driver mutations in 
melanoma has significant importance. An example of such a driver mutation 
discovered by this method is PREX2, a PTEN-interacting protein and negative 
regulator of PTEN, which was found to have a mutation frequency of approximately 
14% in a study of 107 melanomas (Berger et al., 2012).  
 
VIII. Defects in the repair of UV-induced damage in skin cancer 
predisposition 
The mechanisms by which UVB and UVA, as well as other endogenous and 
exogenous damaging agents, are able to induce a variety of DNA lesions with the 
potential to generate different mutations, highlights the need for signalling pathways 
that both recognise the damage sites and activate pathways that lead to the repair of 
these lesions. The significant importance of such pathways is exemplified by genetic 
disorders in which components of DNA repair pathways or pathways upstream of 
these are deficient in activity or absent altogether and can result in the patient 
possessing predispositions to particular disease outcomes. An excellent example of 
this in regards to skin cancer is in the genetic disorder Xeroderma pigmentosum. 
Xeroderma pigmentosum (XP) is a group of related autosomal recessive inherited 
disorders, clinically characterised by early onset development of skin cancer, 
particularly in sun-exposed skin (Satokata et al., 1992). XP was the first syndrome in 
which cellular defects in DNA processing pathways were associated with a clinical 
phenotype (Cleaver, 1968). Skin is normal in affected newborns, but prominent 
sunburn reactions can occur during infancy. From early childhood, XP patients are 
highly likely to develop multiple skin tumours, both non-melanoma and melanomas, 
as well as experience premature skin aging and pigmentary changes (Nikolaou et al., 
2012). A median onset age of 8-9 years is seen in patients who are not protected 
from sun exposure. Compared with the remaining population, XP patients have a 
10,000-fold increase in NMSC incidence and a 2,000-fold increase in melanoma 
(Menck and Munford, 2014).  
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XP has been classified into eight different complementation groups, XP-A through to 
XP-G, and XP variants (XP-V), with each group corresponding to mutations in eight 
different genes. Seven of the genes, which account for groups XP-A through XP-G 
are involved in the repair of DNA lesions via NER. XP-V patients are NER proficient 
and are able to remove generated lesions but are unable to replicate DNA following 
UV exposure as they are deficient in translesion synthesis (Menck and Munford, 
2014). XP-C, in complex with RAD23b, is responsible for DNA damage recognition in 
GG-NER, whilst the remaining XP genes, with the exception of XP-V, are common to 
both GG-NER and TC-NER. XP patients are therefore at increased risk of developing 
skin cancers as they are inefficient at recognising and removing pyrimidine dimers 
generated by both UVB and UVA exposure. As a result, the characteristic C to T 
transitions and CC to TT tandem base substitutions that make up the mutation 
signature of UV-induced pyrimidine dimers occur more frequently.  
There are some discrete clinical characteristics between the different 
complementation groups, for example, XP-A patients may also have some 
neurological impairment whilst XP-C patients are at a particular risk of developing 
melanomas (Yang et al., 2007, Lynch et al., 1984). Interestingly, it has been shown 
that proteins involved in GG-NER damage recognition play a crucial role in deciding 
a cell’s fate by triggering the initiation of the repair pathway or by signalling apoptosis 
(Stoyanova et al., 2009). Consequently, if the GG-NER pathway was defective, 
neither DNA repair or apoptosis initiation can occur, generating cancer cells that 
cannot undergo apoptosis and contains high levels of UV-induced mutations 
(Pleasance et al., 2010). A recent paper has demonstrated that GG-NER is deficient 
in melanoma cells following UVA exposure (Murray et al., 2016). Pathogenic 
mutations in components of GG-NER (XP-C) lead to XP whilst mutations in TC-NER 
components, such as ERCC8 and ERCC6 result in Cockayne’s syndrome, which is 
characterised by neuronal abnormalities but no increased incidence of skin cancer. 
The involvement of XP-C in GG-NER and the understanding that GG-NER is 
deficient in melanomas following UVA exposure explains why patients of the 
complementation group XP-C have an increased incidence of melanoma skin cancer.  
 
IX. The DNA damage response 
Genome injury, not only from DNA lesions generated following UV exposure but also 
other genotoxic stress sources to which all living organisms are constantly exposed 
to, must be repaired to prevent the mutational outcomes that can occur. In order to 
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preserve the information that DNA encodes, cells must detect the damage and 
propagate signals to ensure the correct repair pathways are initiated. This is 
accomplished through a cascade of mechanisms that together encompass the DNA 
damage response (DDR), which can detect the variety of potential lesions and 
manage the frequency at which they are generated. The DDR can be divided into 
multiple distinct but functionally similar pathways, largely depending on the type of 
DNA lesion being detected and repaired (Lord and Ashworth, 2012). The pathway to 
be activated following lesion detection is determined by the activation of PI3K-like 
kinases (PIKKs) family proteins, which include ataxia-telangiectasia mutated (ATM), 
ataxia-telangiectasia and Rad3-related (ATR) and DNA-dependent protein kinase 
catalytic subunit (DNA-PKcs), which are responsible for phosphorylating various 
components of the DDR in order to coordinate cell cycle arrest and DNA repair 
pathway activation (Sulli et al., 2012) (Figure 1.4). In the event that the damage 
cannot be repaired, the DDR is able to induce cell death through either apoptosis or 
cellular senescence.  
The DDR comprises two main DNA damage sensors, the MRE11-RAD50-NBS1 
(MRN) complex, which detects DSBs, and replication protein A (RPA) and the RAD9 
RAD1-HUS1 (9-1-1) complex, which detects replication stress by recognising stalled 
replication forks. The NBS1 component of the MRN complex has been demonstrated 
as being dispensable for the binding of the whole complex to DSBs (Mirzoeva and 
Petrini, 2001). MRE11/RAD50 binds to DNA as a heterotetramer that tethers the 
broken ends of DSBs, due to two DNA-binding motifs possessed by MRE11 (van den 
Bosch et al., 2003, de Jager et al., 2001). The architecture of the MRN complex is 
altered upon DNA binding, generating a parallel orientation of the coiled-coils of 
RAD50 to create a configuration that favours intercomplex association (Lavin, 2007). 
MRE11 possesses both endonuclease and exonuclease activity which are stimulated 
by association with RAD50 and activated upon binding to DSBs. MRN then resects 
DSBs, generating short 3’-ssDNA tails that are immediately coated by RPA (Huhn et 
al., 2013). This process of DSB resection is required for homologous recombination 
but not for NHEJ and therefore serves as an important step in determining how DSBs 
are repaired (Polo and Jackson, 2011). In the same manner that RPA detects 
regions of ssDNA generated by MRN resection, RPA is responsible for detecting 
stalled replication forks following replicative stress by again detecting regions of 
ssDNA. In these cases, RPA then recruits the 9-1-1 complex to activate a different 




















Figure 1.4. The DNA damage response 
The DNA damage response (DDR) encompasses a cascade of reactions responsible for detecting 
different types of DNA damage and then signalling for their repair following cell cycle arrest. Two 
main DNA damage sensors are involved in the pathway, the MRN complex (a), which recognises 
DNA double strand breaks (DSBs); and RPA and the 9-1-1 complex (b), which together are 
responsible for recognising stalled replication forks generated by replication stress. The DNA 
damage sensors recruit the apical kinases ATM and ATR, via the MRN and 9-1-1 complex, 
respectively. ATM and ATR can phosphorylate a number of DNA damage mediators such as the 
histone variant H2AX at Ser139 to generate H2AX, in the region proximal to the detected lesion. 
ATM can phosphorylate 53BP1 and MDC1, which form a positive feedback loop by enhancing ATM 
accumulation and activity to sustain DDR signalling. Eventually, DDR signalling pathways lead to 
the engagement of the diffusible kinases Chk2, which is phosphorylated by ATM, and Chk1, which 
is phosphorylated by ATR. These downstream kinases can then phosphorylate a number of effector 
proteins such as p53 and CDC25 phosphatases. The effectors are then responsible for propagating 
the actions of the DDR such as inducing cell cycle arrest so that the DNA lesions can be repaired 
before the proliferation resumes. However, in the event that the damage cannot be repaired, the 
DDR can induce cellular senescence or apoptosis.  
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complex recruit and activate the two large protein kinases ATM and ATR, 
respectively. 
Whilst the NBS1 complex is not needed for the binding of the MRN complex to DSBs, 
it is required for the binding of ATM to the complex as indicated by cells expressing a 
truncated form of NBS1 lacking its 20 C-terminal residues (Falck et al., 2005). 
Experiments have shown that ATM recruitment to NBS1 requires that the MRN 
complex is DNA-bound. Ionising radiation treatment of soluble extracts containing 
ATM and MRN did not enhance complex formation, whilst addition of dsDNA 
oligonucleotides from untreated cells to the extracts resulted in increased NBS1-ATM 
association. Activation of ATM by interaction with MRN results in the 
autophosphorylation of ATM at Ser1981. Single-stranded DNA generated at stalled 
replication forks or following dsDNA resection by MRN is recognised and bound by 
RPA, which generates a signal for ATR recruitment via its partner protein ATR-
interacting protein (ATRIP) (Cortez et al., 2001). ATR kinase activity is boosted by 
recruitment of both the 9-1-1 complex by RPA and by topoisomerase-II-binding 
protein 1 (TOPBP1) (d'Adda di Fagagna, 2008). Once activated, the two kinases are 
able to phosphorylate multiple targets, some of which are common to both ATM and 
ATR, in order to further propagate the DDR.  
One important component of the DDR that is a common target for both ATM and 
ATR is the histone variant H2AX. The kinases phosphorylate H2AX at Ser139 to 
generate H2AX, foci of which are rapidly generated at DSB sites and are thought to 
be required for further recruitment of repair factors. This positive feedback loop, to 
which mediator of DNA-damage checkpoint 1 (MDC1) and p53-binding protein 1 
(53BP1) are crucial, causes the recruitment of additional ATM in order to amplify 
ATM activity, resulting in the spread of H2AX along the chromatin (Lou et al., 2003, 
Abraham, 2002). For a while, H2AX was classified as a biomarker for DSB 
formation, with studies demonstrating that DSB formation via ionising radiation or 
cytotoxic agents causes rapid H2AX phosphorylation (Kuo and Yang, 2008). 
However, whilst it is true that DSB formation is complemented by H2AX formation, 
not all H2AX formation can be attributed to DSBs as other forms of DNA lesions, 
such as stalled replication forks, can also generate H2AX (Cleaver et al., 2011, 
Cleaver, 2011). Following DNA damage repair, the foci are disassembled, which is 
attributed to the actions of chromatin remodelling machinery and also dedicated 
phosphatases, which dephosphorylate H2AX (Downey and Durocher, 2006).  
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H2AX is just one of hundreds of targets of the apical kinases ATM and ATR. Two of 
the most important and best studied targets are the diffusible protein kinases Chk2 
and Chk1, which are specifically targeted by ATM and ATR, respectively. These 
targets function to reduce cyclin dependent kinase (CDK) activity by various 
mechanisms, including those mediated by the transcription factor p53 and cell-
division cycle 25 (CDC25) (Jackson and Bartek, 2009). Inhibition of this activity helps 
to bring about cell cycle arrest at the various cell cycle checkpoints. ATM is able to 
directly phosphorylate p53 at Ser15, which enhances the activity of p53 as a 
transcription factor (Banin et al., 1998). Chk2 is able to phosphorylate p53 at Ser20, 
which interferes with the p53-MDM2 interaction, causing the complex to dissociate. 
MDM2 is an ubiquitin ligase and targets p53 for proteasome-mediated degradation 
(Ryan et al., 2001). This dissociation and the enhancement of p53 activity allows it to 
induce the transcription of p21, a CDK inhibitor, which results in cell cycle arrest 
(Deng et al., 1995). Chk1 is responsible for phosphorylating the checkpoint 
phosphatase CDC25, which marks it for degradation. Normally, CDC25 functions to 
dephosphorylate and maintain the activity of CDK2 and CDK1. CDK2 governs the 
G1-S transition and S phase progression whilst CDK1 governs transition from G2 into 
mitosis (Falck et al., 2002). Therefore, DNA-damage induced CDC25 inactivation 
prevents cell-cycle checkpoint transition and results in cell cycle arrest. ATM, ATR, 
Chk2 and Chk1 also activate a number of targets involved in activating the various 
DNA damage repair pathways, with different targets activated depending on the type 
of lesion to be repaired.  
 
X. UVR and the DNA damage response 
As with all exogenous and endogenous damaging agents, studying the mechanics of 
the DDR in response to these agents can provide significant insight into the 
mechanisms by which they generate damage and how their repair is initiated. UVR is 
no exception and a number of research groups have looked at both UVB and UVA 
and how the DDR is affected by them. One of the initial stages of the DDR is the 
activation and recruitment of ATM and ATR following the detection of different DNA 
lesions by the MRN and 9-1-1 complexes, respectively. UVA and UVB have been 
shown by several studies to be able to increase the levels of both ATM and ATR, 
suggesting that both DSBs and replication stress are involved in the DNA damaging 
mechanisms of UVR (Ray et al., 2016, Girard et al., 2008). A key target for ATM and 
ATR and thus a key component in the DDR is the histone variant H2AX. Its 
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phosphorylation on serine 139 to yield H2AX, is associated with DSB repair and 
other lesions formed following UVR exposure (Barnes et al., 2010).  
In 2010, Barnes et al. demonstrated that H2AX can be used as an accurate 
biomarker for detecting genotoxic stress caused by UV-irradiation both in vitro, in 
both keratinocyte cell culture and within an artificial epidermis, as well as in vivo in 
human skin. They showed that apparently stress-free keratinocytes activated H2AX 
as a result of damage from endogenous sources, especially within S phase, but this 
activation increased following exposure to 0.1 kJ m-2 UVB with maximum activation 
seen 2 h post exposure and baseline levels returning at 24h. A dose of 0.2 kJ m-2 
however resulted in much greater activation with maximum activation at 8 h post 
exposure. Similar results were observed following application of the same doses of 
UVB to an artificial epidermis, which demonstrated a significant increase in signal 
throughout the entire epidermis 2 h post irradiation. An even higher signal intensity 
seen for the higher dose, with a maximum reached at 8 h post exposure. In vivo 
investigations in four volunteers showed that 24 h post irradiation, the majority of the 
epidermal and dermal cells had intense pan-nuclear staining for H2AX. They also 
found a correlation of UVB-induced phosphorylation of both H2AX and p53.  
The involvement of H2AX in the UVR-induced DDR was both supported and 
expanded upon by investigations into DNA damage of mice skin following UVA and 
UVB irradiation at physiological doses in mice skin (Svobodová et al., 2012). A 
significant dose dependent increase in H2AX positive cells was seen in the basal 
layer and entire epidermis following UVB at both 2 kJ m-2 and 8 kJ m-2 at both 4 h 
and 24 h post irradiation. UVA at doses of 100 and 200 kJ m-2 did not stimulate 
H2AX formation, which was in agreement with other papers that sunburn cells are 
not produced following UVA irradiation (Takeuchi et al., 2004, Lavker and Kaidbey, 
1997). However, there are inconsistencies in the research regarding the ability of 
UVA to induce H2AX formation, as other studies have shown that UVA can induce 
H2AX formation (Stixova et al., 2014, Wischermann et al., 2008). Wischermann et 
al. (2008) used UVA doses of 100 to 600 kJ m-2 and observed a dose-dependent 
increase in the number of H2AX foci generated following UVA exposure.  
Another key player in the DDR is the transcription factor p53, which has been termed 
the ‘guardian of the genome,’ due to its important function as a tumour suppressor 
and cell-cycle regulator (Menendez et al., 2009). The importance of p53 in the DDR 
following UVR exposure is highlighted by evidence that mice which possess a p53 
knockout are hyerpsensitive to the induction of skin cancers by UVR exposure (Jiang 
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et al., 1999). In comparing how DDR component activation in primary human skin 
cells differ following exposure to UVA or UVB irradiation, Runger et al. (2012), using 
the same physiological and equimutagenic doses (100-300 J m-2 UVB, 100-300 kJ  
m-2 UVA) found that UVB was more prominent at inducing p53-mediated cell cycle 
arrest than UVA. This was due to UVB being able to cause phosphorylation of p53 at 
Ser15 more efficiently than UVA. Similar doses applied to mice skin by Svobodova et 
al. (2012) observed similar increases in phospho-p53, again with the increase being 
more apparent in UVB treated mice. The increased p53-mediated cell cycle arrest 
seen following UVB could explain why lesions generated by UVA have greater 
toxicity and mutagenic potential, due to the decreased time available for the lesions 
to be repaired.  
Recent studies have reported that signal transducer and activator of transcription 3 
(STAT3) is required for efficient repair of UV-induced DNA lesions by modulating the 
ATM-Chk2 and ATR-Chk1 interactions (Liao et al., 2015, Barry et al., 2010). A431 
human epidermoid cancer cells exposed to UVR showed that STAT3 enhanced 
activation of ATR at both mRNA and protein levels and regulated ATR activity 
following DNA damage. STAT3 is also responsible for downregulating the 
transcription of microRNA-383. This miRNA is itself able to suppress ATR activation 
and so these results taken together suggests that STAT3 regulates ATR activation of 
of expression via miRNA. This provides increasing evidence for the role of miRNAs, 
which are critical regulators of gene expression, in the DDR. The miRNA was found 
to target the 3’-untranslated region of ATR mRNA, downregulating ATR activation, 
whilst STAT3 functions to downregulate the miRNA-383 promoter. Alternatively, 
there is evidence that miRNA expression following UVR exposure can result in 
enhancement of the DDR (Pothof et al., 2009). Here, silencing of essential 
components of the miRNA processing pathway, such as Dicer and Ago2, 
compromised cell survival and checkpoint response following UV exposure. 
Furthermore, it has been demonstrated that UVA and UVB irradiation of human 
primary keratincoytes differentially regulates the expression of several cellular 
miRNAs (Kraemer et al., 2013). They demonstrated miRNAs expressed specifically 
following either UVB or UVA irradiation, such as miR-23b, a human keratinocyte 
differentiation marker, which was up-regulated following UVA irradiation.  
A recent study has provided insight into the DDR of human melanocytes following UV 
irradiation. MC1R, a G protein-coupled receptor important in human pigmentation 
diversity, was shown to be activated by -melanocortin following UVR exposure 
(Swope et al., 2014). This leads to enhancement of CPD repair by upregulation of 
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XPC, the enzyme responsible for the detection of DNA lesions in NER, and 
increased UV-induction of ATM and ATR, ultimately leading to increased levels of 
H2AX. The MC1R gene confers melanoma susceptibility, with some of its alleles 
being strongly associated with red hair phenotype and therefore increased risk of 
melanoma. Expression of two of these alleles, either hetereozygously or 
homozygously resulted in loss of function of MC1R in melanocytes and compromised 
DNA repair capacity.  
Understanding how the different components of UVR effect the mechanics of the 
DDR holds significant importance for understanding how the lesions are generated 
and repaired. Despite making up 90-95% of the terrestrial UVR we are exposed to, 
much less is understood about how UVA contributes to carcinogenesis in comparison 
to UVB. This research project therefore aims to look at how environmentally relevant 
doses of UVA impact the DNA damage response, with particular emphasis on how 
the DDR changes over time following UVA exposure, providing insight into how the 
DDR remains activated when cells are no longer exposed to UVA irradiation. The 
project will also consider the role of the UVA-induced bystander effect on DDR 
activation. Considering how directly irradiated cells can influence the DDR in nearby 
cells which received no irradiation is important due to the fact that not all cells within 
the skin will absorb UVR, but can still become damaged due to signals received 

















2. Materials and Methods  
 
I. Media and Buffers 
Table 2.1 
Buffer/Media Name Components pH 
Lonza BioWhittakerTM 
Dulbecco’s Modified Eagle’s 
Medium w/ 4.5 g/L Glucose 
w/ L-glutamine and phenol 
red 
Supplemented with 10% FCS and 100 U/ml 




Dulbecco’s Modified Eagle’s 
Medium w/ 4.5 g/L Glucose 
w/o L-glutamine and phenol 
red 
Supplemented with 10% FCS and 4 mM L-
glutamine (Gibco)  
7-
7.4 
10X TGS 250 mM Tris (Melford), 1.92 M glycine 
(Melford), 1% SDS  
8.3 
10X TBST 10X TBS solution (Melford) contains 0.25 M 
Tris, 1.37 M NaCl, 0.027 M KCl. 1X TBS 
solution contains 0.1% Tween-20 (Sigma) 
7.6 
RIPA++ buffer 25 mM Tris, 150 mM NaCl, 0.1% SDS, 0.5% 
sodium deoxycholate, 1% Triton X 100. 
Supplemented with Roche cOmpleteTM Mini, 
EDTA-free protease inhibitor cocktail tablets 
and Roche PhosSTOP phosphatase inhibitor 
cocktail tablets  
7.4 
Semi-dry transfer buffer 7.2 g Trisma base (Sigma), 0.44 g CAPs 
(Sigma) 20 ml ethanol (Fisher), 0.4 ml 10% 











Antibody Concentration used Supplier 
Histone H2AX (pSer139) 
Mouse monoclonal 
antibody 







Western blot 1:2000 Cell signalling 
technologies (from cell 
cycle/checkpoint antibody 
sampler kit) (9917T) 
Purified mouse anti-actin 
Ab-5 monocolonal 
antibody 
Western blot 1:2000 BD Bioscience (612656) 
Sheep anti-mouse IgG 
(HRP) polyclonal 
secondary antibody 
Western blot 1:4000 Abcam (ab6808) 
Goat anti-rabbit IgG 
(HRP) polyclonal 
secondary antibody 
Western blot 1:4000 Abcam (ab9721) 




Life technologies  
(A-11001) 
 
III. Cell culture 
HaCaT keratinocytes were cultured in 75 cm2 cell culture flasks in 20 ml DMEM 
supplemented w/ 4.5 g/L glucose w/ L-glutamine and phenol red (Lonza, Table 2.1) 
and grown at 37oC 5% CO2. The cells were passaged when 80% confluency was 
reached. The media was removed from the culture cells and the cells washed once 
with PBS, using at least the same volume of PBS as culture media. Cells were 
treated with 12 ml of 0.5 mM EDTA (Invitrogen) in PBS and incubated at 37oC 5% 
CO2 for 12 min. This helps to detach the desmosomes. The PBS-EDTA was removed 
and 1 ml 0.25% trypsin-EDTA (1X) (Gibco) was added. The cells were incubated at 
37oC 5% CO2 until they had detached. The trypsinisation reaction was neutralised by 
addition of 2 ml supplemented DMEM. The cells were pelleted by centrifugation at 
5000 x g 5 min. The supernatant was removed and the cells resuspended in DMEM. 
For experiments where cells were to be irradiated, cells were resuspended in phenol 
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red free DMEM. Cell counts were performed and the required volume prepared 
according to the assay or experiment to be performed. 
 
IV. Ultraviolet A irradiation 
In this experiment, UVA doses up to 100 kJ m-2, which represents an environmentally 
relevant dose, were used. Cells were seeded into different types of culture dishes at 
densities suitable for the experimental demands and were grown until attachment. All 
irradiations were performed in DMEM supplemented with FCS and L-glutamine and 
did not contain phenol red as it can function as a photosensitiser (Table 2.1). UVA 
irradiation was performed using seven Phillips TLR 36W tubes. Wavelengths below 
320 nm were filtered out using Mylar film. The UVA output was measuring using a 
double monochromator spectroadiometer (Model SR911-PC, Macam Photometrics, 
UK) with peak output measured at 365 nm. 
 
V. Inhibitor and drug treatments 
Various compounds that inhibit different components of the DNA damage response 
or induced DNA damage were used. For each inhibitor, cells were pretreated for 1 h 
prior to irradiation with UVA. ATM inhibitor (Ku-60019, Selleckchem) and ATR 
inhibitor (VE-821, Selleckchem) were used at concentrations up to 1.0 M, 
depending on the experiment being carried out. PI3K inhibitor (LY294002, Cell 
guidance systems) was used at a concentration of 50 M. Mirin (CAS 299953-00-7, 
Santa Cruz) an inhibitor of the MRN complex, was used at a concentration of        
100 M.  
 
VI. Cell viability assays 
The effect of UVA in conjunction with inhibitor treatments on cell viability was 
monitored by MTT and XTT assays, colourimetric assays for assessing cell metabolic 
activity. In both cases, HaCaT cells were seeded in 96-well plates at a density of 
5000 cells/well in a total volume of 100 l phenol red free DMEM per well. Cells to be 
irradiated with UVA were seeded on separate 96-well plates. The cells were treated 
with various DNA damage response component inhibitors in triplicate and incubated 
at 37oC 5% CO2 for 1 h before UVA exposure. Following UVA irradiation, the plates 
were incubated at 37oC 5% CO2 for 24 h.  
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Next, for the MTT cell viability assay, 20 l 5 mg/ml MTT solution was added to each 
well and plates incubated at 37oC 5% CO2 for 3 h. A triplicate set of control wells 
containing MTT only was included. The media was carefully removed without 
disturbing the cells and without rinsing with PBS. Formazan crystals in each well 
were dissolved in 150 l DMSO. Cells were agitated on an orbital shaker for 15 min 
and absorbance measured at 540 nm.  
The XTT cell viability assay was performed using the Biotium XTT cell viability kit. 25 
l activated XTT solution (which gives a broader dynamic range of detection versus 
50 l activated solution) was added to the medium in each well. The plates were 
incubated for 3 h at 37oC 5% CO2. The absorbance signal of the wells were 
measured at a wavelength of 490 nm whilst background absorbances were 
measured at 630 nm. Absorbances were measured using a BioTek ELx808 
absorbance microplate reader.  
 
VII. Western blot analysis 
For obtaining protein extracts, HaCaT cells were seeded at 3 x 106 cells per 60 mm 
cell culture dish and grown until 70-80% confluent prior to UVA irradiation. Following 
irradiation, the media was removed and the cells washed with 1X PBS. Residual PBS 
was removed using an aspirator. Total protein extracts were obtained by addition of 
150 l RIPA++ (contains protease and phosphatase inhibitors; Table 2.1) and 
harvesting with a cell scraper before being transferred to microcentrifuge tubes. Cells 
were harvested on ice at various points post irradiation according to the demands of 
the experiment. Cellular debris was pelleted by centrifugation at 13,000 rpm for 10 
min at 4oC. Protein concentrations were determined via Bradford assay using 
RIPA++ to generate a blank and various concentrations up to 1 mg/ml BSA (Sigma-
Aldrich) were used to generate a standard curve. The samples were normalised to 
each other and the volumes required for 10 mg of each sample was determined. The 
volume was made up to 10 l with 1X PBS and samples boiled for 10 min in 3X SDS 
loading buffer (188 mM Tris-Cl (pH 6.8), 3% SDS, 30% glycerol, 0.01% bromophenol 
blue, 15% -mercaptoethanol). Protein extracts were electrophoresed in 1X TGS 
running buffer (Table 1) on a 4-15% gradient TGX gel (Bio-Rad) at 200V. Using a 
semidry transfer at 63 mA constant (per gel) for 2 h, the proteins were blotted on to 
Immobilon-P polyvinylidene difluoride membrane (Sigma-Aldrich). Prior to transfer, 
the PVDF the membrane was activated by addition of methanol, which was then 
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removed and excess washed off. After blocking with 5% w/v non-fat milk in 1X TBST, 
membranes was incubated with primary antibody (Table 2.2), which was diluted in 
5% milk in 1X TBST. Prior to incubation with the secondary antibody, the membrane 
was washed three times with 1X TBST. The membrane was then washed five times 
with 1X TBST and the antibodies detected using Pierce ECL Plus western blotting 
substrate (Thermo Scientific). Western blot images were taken using a Bio-Rad 
ChemiDocTM MP system.  
 
VIII. Immunofluorescence  
For immunofluorescence experiments, 2 x 105 cells were seeded onto 15 mm 
coverslips, which were contained within 35 mm cell culture dishes. Following UVA 
irradiation, cells were washed once with 1X PBS and fixed with 4% PFA at room 
temperature for 20 min. For experiments where replicating cells were to be detected, 
a Click-iT® EdU Alexa Fluor 555 Imaging kit (C10339, Invitrogen) was used to label 
replicating cells. 10 M EdU (component A) was added at 1:1000 to the coverslip and 
incubated for 1 h prior to fixation. Cells were fixed at various points following 
irradiation to comply with demands of the experiment. After fixation, cells were 
washed three times in PBS and then permeabalised in 0.5% Triton X 100 in PBS at 
room temperature for 10 min. The permeabilisation buffer was removed and the 
coverslips washed three times in 1X PBS. 500 L of Click-iT reaction cocktail per 
coverslip was prepared according to the instructions provided by the kit. The plates 
were incubated for 30 min at room temperature, protected from the light. All 
subsequent incubation steps were carried out with the samples protected from the 
light. The coverslips were washed three times in PBS and were transferred onto 
labelled Para film in a humidified chamber. Fresh 3% BSA in PBS was used to block 
the fixed cells for 1 h at room temperature. The coverslips were incubated for 1 h in 
H2AX primary antibody (Table 2.2) at a concentration of 1:400 in 3% BSA in PBS. 
The coverslips were washed three times in 1X PBS prior to 1 h incubation with the 
anti-mouse Alexa fluor 488 secondary antibody, 1:1000 in 3% BSA in 1X PBS (Table 
2.2). Following incubation with the secondary antibody, coverslips were washed five 
times in PBS and rinsed with ddH2O. Excess water was removed from the coverslips 
and they were then mounted onto slides using Vectashield mounting medium 
containing DAPI (Vector Labs). Once dried, the slides were sealed with clear nail 
varnish and stored at 4oC, shielded from light ready for visualisation by microscopy 
using a Zeiss LSM 880 confocal microscope. Zen from Zeiss was used to generate 
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images and measure the intensity of the AlexaFluor 488 signal in order to quantify 
H2AX activation. Categorical scatter graphs used to display data from each 
analysed nucleus was generated using Graphpad Prism 7.  
 
IX. Bystander effect experiments 
To investigate the ability of UVA to induce the radiation-induced bystander effect, 
irradiated and nonirradiated cells were co-incubated in six well dishes, with a sterile 
insert separating the two cell populations by a 1-m-pore membrane (Greiner bio-
one) to allow diffusion of medium components between the two populations. The 
experimental design is outlined below in Figure 2.1a. The mechanism by which 
signals pass between the separate cell populations is shown in Figure 2.1b. The co-
culture method used does not require collection and transfer of conditioned media 
between cell populations, providing an improvement over some previous methods 
used to investigate the radiation-induced bystander effect. The model allows partial 
simulation of the skin environment to be made as it allows investigation of paracrine 
signalling between differentially treated feeder and bystander cells to be investigated. 
This would be the case within the skin as not all cells would directly absorb UVA 
radiation. 
HaCaT cells were seeded at a density of 5000 cells/insert in 1 ml phenol red free 
DMEM (Table 2.1) and were incubated in six-well plates with each well containing 2 
ml phenol red free DMEM. These would be the irradiated cells. For experiments 
where immunofluorescence was to be carried out, coverslips were placed in the wells 
of separate six-well plates and HaCaT cells seeded at a density of 1 x 105 cells/well 
in 2 ml phenol red DMEM. For experiments where clonogenic analysis was to be 
carried out, cells were seeded at a density of 200 cells/well in 2 ml phenol red 
DMEM. These would be the nonirradiated bystander cells. Phenol red is a 
photosensitiser, therefore, phenol red and antibiotic free medium was used for the 
irradiated cells. Phenol red medium was used for the bystander cells to prevent 
infection following extended periods of incubation, as the medium is supplemented 
with penicillin and streptomycin. Inserts which were to be irradiated with UVA or 
different doses of UVA were incubated in separate six-well plates. Immediately prior 
to irradiation, the nonirradiated control inserts were transferred to six-well plates 
containing the nonirradiated bystander cells and following irradiation with UVA, the 






The plates were incubated at 37oC 5% CO2 and bystander cells processed according 
to the experimental demands.  
 
X. Clonogenic analysis 
The UVA-induced bystander effect was investigated using clonogenic survival 
assays. HaCaT cells were seeded in inserts at a density of 5000 cell/well and the 
bystander cells seeded at a density of 200 cell/well in six-well plates. Each 
experimental condition was set up in triplicate. Prior to irradiation, the nonirradiated 
control inserts were transferred to six well plates. The remaining inserts were 
Figure 2.1. Bystander effect experimental design 
(a) HaCaT keratinocytes to be irradiated were seeded at a density of 5000 cells/insert. The 
bystander cells were seeded at densities of either 1 x 105 cells/well for immunofluorescence, in 
which the wells also contained a coverslip, or 200 cells/well for clonogenics. Post-irradiation, the 
inserts were transferred to the six-well plates containing the bystander cells. Control inserts 
containing cells that had not received any irradiation were transferred prior to any irradiations. The 
plates containing both the inserts and bystander cells were incubated according to the experimental 
demands. (b) Example of the co-culture system used to induce the bystander effect following the 




irradiated with 12.5, 25, 50 and 100 kJ m-2 UVA and then immediately transferred to 
six well plates containing the bystander cells and incubated at 37oC and 5% CO2. 
After seven days, the resulting colonies were fixed in 70% ethanol (Fisher) with 20 
min incubation at room temperature and stained with 5% Giemsa (Fluka) through 20 
min incubation at room temperature. The stain was removed to waste and the wells 
washed with water and left to air dry. For each well, the number of colonies was 





























Ultraviolet radiation is composed of different waveband components, UVA, UVB and 
UVC. The main source of UVR is solar radiation and the atmosphere is able to 
absorb all of the UVC waveband, 90-95% of the UVB waveband whilst the UVA 
waveband is not absorbed. Consequently, the terrestrial UVR that we are exposed to 
from the sun consists of 90-95% UVA with the remainder being UVB. Both 
wavebands can damage cellular biomolecules, which includes DNA, and the 
resulting lesions can lead to mutations that can contribute towards carcinogenesis. 
Although both wavebands damage DNA, the theoretical mechanisms by which they 
do so are thought to differ, with direct absorbance of UVB by bases leading to the 
generation of pyrimidine dimers the accepted mechanism for UVB. On the other 
hand, the mechanism by which UVA generates DNA damage remains debatable, 
with both direct and indirect mechanisms proposed. In each case however, the 
generated lesions are detected by the DNA damage response, a cascade of 
reactions that connect the detection of the lesions with the initiation of repair following 
cell cycle arrest. Despite making up the vast majority of terrestrial UVR, the effect of 
UVA on the DNA damage response is relatively understudied in comparison to UVB. 
This research project therefore aims to provide further insight into how the DNA 
damage response is affected by UVA in both directly irradiated cells and 
nonirradiated, bystander cells.  
 
I. UVA irradiation induces a dose-dependent decrease in cell survival 
in HaCaT keratinocytes 
The DDR is responsible, through a number of complexes and mechanisms, for 
recognising different types of DNA damage sites and initiating numerous signalling 
pathways in order to bring about cell cycle arrest. This then allows for the appropriate 
repair mechanisms to be activated before the cell cycle can resume. However, in 
cases in which the damage cannot be repaired, the DDR is able to bring about cell 
death by either inducing senescence or apoptosis. Measuring cell viability, of which 
there are numerous assays and methods available, is a good way of measuring how 
a mutagen, in this case UVA, affects cell viability. Consequently, this can provide 





The XTT cell viability assay was conducted to determine cell viability following 
irradiation with various dosages of UVA. Doses up to 100 kJ m-2 were used. 100      
kJ m-2 is an environmentally relevant dose and reflects the range observed following 
an hour’s exposure in subtropical regions in summer months (Whiteside and 
McMillan, 2009). HaCaT keratinocytes were seeded at low density in triplicate in 96-
well plates and were exposed to different dosages of UVA. The mean percentage 
survival was calculated relative to nonirradiated controls. As shown by Figure 3.1, in 
which mean survival was calculated based on the results of three separate 
experiments, cell viability gradually decreased with an increase in UVA radiation 
dose from 0 to 100 kJ m-2, with a mean percentage survival of 39% (p = 0.001) seen 
with the highest dose used. There was no significant difference in cell survival 
between cells which were exposed to 25 kJ m-2 UVA and those which were exposed 
to 50 kJ m-2 UVA (p = 0.578) but there was a significant decrease in cell survival 
seen when increasing UVA exposure from 50 to 100 kJ m-2 (p = 0.018).  
II. Inhibition of ATM and ATR caused decreased cell viability following 
irradiation with 50 kJ m-2 UVA  
The DNA damage response comprises different DNA damage sensors, which are 
responsible for detecting different types of generated lesions. Whilst the MRN 
complex recognises DSBs, the 9-1-1 complex and RPA cooperate to detect stalled 
replication forks. To evaluate the role of the different arms of the DDR in responding 
to UVA, cell viability following UVA irradiation was investigated in conjunction with 
inhibition of different components of the DDR. An MTT cell viability assay was used 
to investigate how inhibition of ATM, which is downstream of the MRN complex, and 
ATR, which is downstream of the 9-1-1 complex, affected cell survival following 
irradiation with 50 kJ m-2 UVA. Ku-60019 (IC50 = 6.3 nM) was used as the ATM 
inhibitor whilst VE-821 (IC50 = 26 nM) was used as the ATR inhibitor The inhibitors 
are highly selective and specific for their targets with minimal cross reactivity against 
related PIKKs. Concentrations up to 1 M of each inhibitor were used and HaCaT 
keratinocytes seeded at low density in triplicate in 96-well plates as before were pre-
treated with different inhibitor concentrations for 1 h prior to receiving UVA irradiation. 
Appropriate controls which received no UVA exposure were also included. Absolute 
survival in the absence of any irradiation was calculated relative to untreated controls 
to determine how inhibition of ATM and ATR affected the repair of endogenous DNA 
damage. In the absence of UVA exposure, pre-treatment with ATM inhibitor (ATMi) 
and ATR inhibitor (ATRi) at each concentration was not sufficient to decrease cell 



































Figure 3.1. The effect of UVA on cell viability 
HaCaT keratinocytes were seeded in triplicate at 5000 cells/well to a final volume of 100 l in 96-
well plates and allowed to grow for 24 h at 37oC and 5% CO2. Cells were irradiated with various 
doses of UVA from 0 to 100 kJ m-2 and incubated for 24 h. 25 l activated XTT solution was added 
to each well and plates incubated for an addition 3 h. 25 L was used as it provides a broader range 
of detection in comparison to the use of 50 L activated reagent, which reaches signal saturation at 
a lower cell number. Signal absorbance was measured at 490 nm and background signals 
measured at 630 nm. Percentage survival was calculated relative to control cells that received no 
irradiation. The data presented indicates the mean survival and SD for three replicate experiments 
performed. **p < 0.01, ***p < 0.001 indicate the significant differences between the experimental 




































Figure 3.2. Assessment of cell viability following ATM and ATR inhibition at varying 
concentrations in the absence of UVA irradiation 
Cell viability was investigated via MTT cell viability assays whereby cells were seeded in triplicate in 
96-well plates at 5000 cells/well and incubated as with figure 3.1. Cells were pre-treated for 1 h with 
various concentrations of ATMi (a) or ATRi (b). Appropriate controls that received no DDR inhibition 
were included. Cell growth was detected by MTT assay with DMSO used to dissolve the formazan 
crystals and absorbance was measured at 540 nm. Cell survival was calculated for each condition 
in which cells were pre-treated with ATMi or ATRi relative to the untreated control condition. The 





Following this, relative cell survival was calculated to determine how the introduction 
of UVA irradiation following ATM or ATR inhibition affected cell viability. Pre-
treatment with ATMi and ATRi at each concentration caused decreased cellular 
survival following UVA irradiation relative to nonirradiated controls which had been 
treated with the same concentrations in a dose-dependent manner (Figure 3.3). Pre-
treatment with 200 nM ATMi and ATRi followed by UVA exposure caused cell 
viability to decrease to 56% (p < 0.05) and 49% (p < 0.05), respectively, at which 
point the decrease in relative cell survival appeared to plateau, suggesting that 0.2 
M was the point at which saturation was reached for each inhibitor. This 
concentration was used for subsequent experiments due to its ability to decrease cell 
survival by approximately 40-50%.  
 
III. Inhibition of ATM and ATR did not decrease cell viability at a higher 
dose of UVA  
In order to investigate cell viability following UVA irradiation and DDR component 
inhibition further, additional components were inhibited along with ATM and ATR 
prior to irradiation with a higher dose of UVA than before (100 kJ m-2). Here, pre-
treatment with 200 nM ATMi or ATRi was compared to inhibition of PI3K (50 M 
PI3Ki) and the MRN complex (100 M mirin). The XTT assay is a more robust 
method for measuring cell viability as it bypasses flaws associated with the MTT 
assay. HaCaT keratinocytes were pre-treated with the relevant inhibitors for 1 h prior 
to being irradiated with UVA. Again, survival was calculated for the nonirradiated 
control conditions relative to controls that were completely untreated. Relative 
survival was then calculated for each irradiated experimental condition relative to the 
nonirradiated control which received the same inhibitor pre-treatment.  
Once again, pre-treatment with 200 nM ATMi and ATRi did not significantly impact 
cell survival in the absence of UVA exposure and a similar observation was seen for 
nonirradiated controls pre-treated with PI3Ki and mirin (Figure 3.4). As with Figure 
3.1, direct irradiation with 100 kJ m-2 UVA caused cell survival to decrease by 
approximately 60% (p = 0.002). With the exception of PI3Ki (p = 0.184), the 
introduction of UVA caused a significant decrease in cell survival for the irradiated 
conditions relative to the nonirradiated controls pre-treated with the same inhibitors (p 
< 0.05). However, unlike in Figure 3.3 where the inclusion of 200 nM ATMi or ATRi 
caused cell survival to decrease further compared to when cells were treated with 50 

























Figure 3.3. Effects of ATM and ATR inhibition on cell viability  
Cell viability was again investigated via MTT cell viability assays as with figure 3.2. Cells were pre-
treated for 1 h with various concentrations of ATMi (a) or ATRi (b). Following this, cells were 
exposed to 50 kJ m-2 UVA irradiation and incubated for 24 h. Appropriate controls that received no 
DDR inhibition, no UVA exposure or were completely untreated were included. Cell growth was 
detected as with Figure 3.2. Cell survival for each condition in which cells were exposed to 50 kJ m-2 
UVA irradiation following ATMi or ATRi pre-treatment were calculated relative to nonirradiated 
controls pre-treated with the same inhibitor concentrations (Figure 3.2). The data shown represents 
the mean survival and SD for triplicate repeats measured in a single experiment. *p < 0.05 indicates 
the significant differences between the experimental conditions and the control group which 
received no UVA irradiation and pre-treatment with the same inhibitor concentration. 
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to 100 kJ m-2. This was also seen for the instance in which PI3K and the MRN 
complex were inhibited as cell survival following PI3Ki and mirin pre-treatment prior 
to irradiation with 100 kJ m-2 UVA did not significantly decrease compared to UVA 
irradiated cells which received no DDR inhibition.  
 
IV. Direct irradiation with UVA and the resulting impact on the DNA 
damage response 
As well as looking at how direct irradiation with various doses of UVA, both in the 
absence and in the presence of various inhibitors for DDR components, impacted cell 
viability by MTT and XTT assays, western blot analysis was also conducted. This 
was done in order to investigate how activation of components of the DDR changes 
over time following direct UVA exposure. Cells were irradiated with 100 kJ m-2 UVA 
and protein extracts obtained at specific time points post-irradiation. This dose was 
chosen as it resulted in a 60% decrease in cell survival over the course of an XTT 
assay (Figure 3.1 and 3.4) and would likely produce a significant number of DNA 
Figure 3.4. Further analysis of the effects of DDR component inhibition on cell survival 
following UVA exposure 
HaCaT keratinocytes were seeded into 96-well plates and grown as before and cell survival 
determined by XTT assay as performed in figure 3.1. Cells were pre-treated with 200 nM ATMi, 200 
nM ATRi, 50M PI3Ki or 100 M mirin for 1 h prior to irradiation with 100 kJ m-2 UVA. Absolute 
survival was again calculated for the control conditions that received no irradiation relative to the 
untreated control which received no DDR inhibition. Relative cell survival was then calculated for 
each irradiated experimental condition relative to the corresponding control which received no 
irradiation. The data shown represents the mean survival and SD from three individual experiments.  
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damage lesions and therefore a pronounced DNA damage response. A component 
of the DDR downstream of both ATM and ATR is H2AX, which is phosphorylated by 
these kinases at Ser139 following DDR activation to generate H2AX, which has 
been well-established as an effective biomarker for DNA damage. As indicated by 
figure 3.5, H2AX activation changed over the course of the experiment following 
direct UVA irradiation. Whilst some H2AX activation was present immediately 
following UVA exposure, activation continued to increase up until 2 h post-irradiation, 
where phosphorylation peaked. There was still some H2AX activation observed at 
16 h post-UVA irradiation and was abolished by 24 h, H2AX activation was 
completely abolished. Chk2 phosphorylation was also analysed. Phosphorylation of 
Chk2 is a key event in the DDR and engagement of this diffusible kinase occurs 
following its phosphorylation by ATM and is responsible for phosphorylating a 
number of effector proteins to bring about the actions of the DDR. The UVA dose 
used was found to induce Chk2 phosphorylation, with maximum activity seen 
immediately following UVA exposure. Chk2 phosphorylation, although at decreased 
levels, was also present 16 h post-irradiation. Minor Chk2 phosphorylation was also 
seen in the 24 h untreated control condition in the figure presented but this was 
absent in the repeat experiments.  
As with the cell viability assays, the effect of direct UVA irradiation on the DDR in 
HaCaT keratinocytes was then investigated further by the inclusion of ATMi. Prior to 
irradiation with 100 kJ m-2 UVA, cells were pre-treated with 0.2 M ATMi and 
incubated for 1 h. Once again, DDR component activation was assessed via western 
blot analysis (Figure 3.6). This analysis indicated that UVA irradiation of cells that 
have been pre-treated with ATMi increases the time required for H2AX to become 
phosphorylated at Ser139 to generate H2AX, as indicated by the delay in peak 
activation from 1 and 2 h post-irradiation to 4 h, with no activation observed at 1 h 
post UVA exposure. Interestingly however, whilst the activation of H2AX changed in 
the first few hours following UVA exposure once ATM was inhibited, the same effect 
was not observed for the phosphorylation of Chk2. Phosphorylation of Chk2 again 
peaked immediately following UVA exposure and gradually decreased over time. It is 
important to note that due to time constraints, this experiment was only completed 



















Figure 3.5. DNA damage response component activation following direct UVA exposure 
HaCaT keratinocytes were seeded at a density of 3 x 106 cells per 60 mm cell culture dish and 
incubated until attachment. The cells were irradiated with 100 kJ m-2 UVA and protein extracts 
obtained at the indicated times post-irradiation using RIPA supplemented with protease and 
phosphatase inhibitors. Cellular debris was pelleted and protein concentrations determined via 
Bradford assay. Samples were ran on a 4-15% gradient TGX gel. Expression levels of H2AX and 
p-Chk2 were examined via western blot analysis with -actin was used as a load control. The data 




V. Further analysis of H2AX phosphorylation following direct UVA 
irradiation via immunofluorescence  
Immunofluorescence experiments were conducted in order to further investigate 
the phosphorylation of the histone variant H2AX following direct exposure to the 
same UVA dose at the same times post-irradiation previously investigated. A 
conjugated AlexaFluor 488 secondary antibody was used to detect H2AX 
activation. Images were taken for each control and experimental condition (Figure 
3.7). The generated signal intensity was determined for each condition using the 
Zen software measure feature. Individual intensity measurements were 
normalised to the mean intensity for that of the control 0 h condition. 
 
Figure 3.6. DDR component activation of UVA irradiated cells following inhibition of ATM 
HaCaTs were seeded at 3 x 106 cells per 60 mm cell culture dish and incubated. Cells were pre-
treated for 1 h prior to UVA irradiation with 0.2 M ATMi. Cells within the experimental condition 
were irradiated with 100 kJ m-2 UVA and protein extracts obtained at the given times post-irradiation 
and analysed by western blot analysis using the same procedure used in Figure 3.4. Expression 
levels of H2AX and p-Chk2 were examined and -actin was used as a load control. The data 













As with the western blot analysis, analysis of fluorescence intensity demonstrated 
that H2AX activation increased over the initial few hours following irradiation with 
100 kJ m-2 UVA with peak intensity seen at 1, 2 and 4 h post-irradiation (Figure 3.8). 
There was no significant difference between the mean normalised intensities 
measured between these three time points. There was no significant difference 
between the two control conditions that received no UVA irradiation (p = 0.569) whilst 
each experimental condition had mean intensities elevated above that of the controls 
(UVA 0 – 8 h, p < 0.001; UVA 16 h, p = 0.0353; UVA 24 h, p = 0.001). Furthermore, 
no significant difference was calculated between cells which were fixed immediately 
following UVA irradiation and those which were fixed 8, 16 and 24 h post-irradiation.  
 
Figure 3.7. H2AX activation following direct UVA irradiation as analysed by 
immunofluorescence. 
HaCaT keratinocytes were seeded onto coverslips contained within 30 mm culture dishes at a 
density of 1.5 x 105 cells/plate and incubated. The cells were irradiated with 100 kJ m-2 UVA and 
cells fixed at the indicated times. Cells were stained with the appropriate H2AX primary and 
AlexaFluor 488 secondary antibodies prior to being mounted using Vectashield which contained 
DAPI. Cells were visualised via confocal microscopy and images taken using Zen software. 
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In addition to measuring the fluorescent intensities for each experimental and control 
condition, the type of staining was also recorded. The types of H2AX staining were 
divided into three types; pan-nuclear staining, in which a H2AX signal was 
distributed over the whole nucleus, H2AX foci, where the nucleus possessed distinct 
foci, and negative where by the nucleus did not shown signs of pan-nuclear staining 
or foci or were not positively stained for H2AX. Figure 3.9a provides representations 
of the different stain types recorded.  
Figure 3.8. Quantification of H2AX activation via measurement of AlexaFluor 488 signal 
intensity for cells directly irradiated with 100 kJ m-2 UVA relative to untreated controls 
AlexaFluor 488 signal intensity was measured using the Zen software measure feature for the cells 
that were stained via immunofluorescence and visualised through confocal microscopy in Figure 
3.7. The mean intensity was calculated for the control condition in which nonirradiated cells were 
fixed at the same time as the cells which were fixed immediately following UVA exposure. All 
intensity values for the control and experimental conditions were then normalised against this mean. 
The data represents the individual normalised values for each condition and the mean normalised 
intensity and SD represent that for three individual experiments, with the exception of the UVA 16 h 
condition, for which only two experiments were conducted. The number of cells in each condition 
was as follows: Control 0 h 334; 24 h 323; UVA 0 h 329, 1 h 323; 2 h 335; 4 h 313; 8 h 311; 16 h 



































Figure 3.9. The effect of direct UVA irradiation on the type of H2AX signal produced 
The HaCaT keratinocytes that were irradiated with 100 kJ m-2 UVA and analysed by 
immunofluorescence as in figure 3.7 and 3.8 were assessed for the type of H2AX signal that each 
cell presented. The types of H2AX signal were divided into three types, pan-nuclear staining 
whereby the H2AX signal was distributed across the whole nucleus, H2AX foci where the nucleus 
possessed distinct foci which had a more intense signal, and negative, in which the nucleus did not 
show signs of pan-nuclear staining or foci or were not positively stained for H2AX. (a) 
Representatives of each staining type are indicated by red arrows where (A) depicts H2AX foci, (B) 
depicts pan-nuclear staining and (C) shows a negatively stained nucleus. Both black and white and 
colour images are shown to help distinguish the types of H2AX staining. (b) The type of H2AX 
staining presented by each cell used for data analysis in figure 3.6 was recorded and the 
percentage for each type of stain for each condition calculated. *p < 0.05, **p < 0.01, indicate the 




The type of stain presented by each cell that had its H2AX signal intensity measured 
was recorded and the percentage type of stain for each condition was calculated 
(Figure 3.7b). Cells which received no UVA exposure were primarily negatively 
stained. Following exposure to 100 kJ m-2 UVA, the percentage of pan-nuclear 
stained cells increased with a peak seen for cells fixed 1 h post-irradiation, after 
which the number of pan-nuclear stained cells decreased. Cells fixed 1, 2 and 4 h 
post-irradiation had the highest number of cells with H2AX foci, with significant 
increases observed relative to nonirradiated controls (UVA 1 h, p < 0.05, UVA 2, 4 h,  
p < 0.01). Additionally, whilst pan-nuclear staining and H2AX foci generation 
increased over the initial few hours following UVA exposure, the number of 
negatively stained cells decreased. By 24 h post-UVA exposure, the number of cells 
that were neither pan-stained or had no H2AX foci had nearly returned to the level 
observed for the nonirradiated controls. 
 
VI. Immunofluorescent analysis of H2AX activation following ATM 
inhibition prior to UVA irradiation 
After using immunofluorescence to analyse H2AX activation following direct 
irradiation with 100 kJ m-2 UVA, immunofluorescence was used to quantify the 
decrease in H2AX activation following pre-treatment with ATMi prior to UVA 
irradiation. Confocal microscopy was again used to image the stained cells for each 
experimental and control condition (Figure 3.10a). Images for the nonirradiated 
controls that were either pre-treated with ATMi or were not, were excluded as there 
was no difference in H2AX activation between the two control conditions and the 
controls included in figure 3.8 and 3.9. The H2AX signal intensity was quantified as 
before and the individual measurements for each control and experimental condition 
was normalised against the mean value for the control in which cells received no 
UVA exposure or ATM inhibition and were fixed at the same time as those fixed 
immediately following UVA exposure.  
As before, irradiation with 100 kJ m-2 UVA, in the absence of ATM inhibition, caused 
a marked increase in H2AX signal intensity relative to untreated controls (Figure 
3.10b). Similarly, cells pre-treated with ATMi prior to UVA exposure had significantly 
increased H2AX activation compared to controls which received ATM inhibition but 
no UVA exposure (p < 0.001). The ATM inhibitor pre-treatment caused the intensity 

















































Figure 3.10. Effect of ATM inhibitor pre-treatment on UVA-induced H2AX activation 
HaCaTs were seeded onto coverslips as in figure 3.6. Prior to irradiation with 100 kJ m-2 UVA, one 
experimental group received 1 h pre-treatment with 200 nM ATMi. Cells were fixed at the indicated 
times following UVA exposure. The appropriate controls which received no ATM inhibition, no UVA 
irradiation or were completely untreated were included. (a) Cells were visualised via confocal 
microscopy and images taken using Zen software. Images for control conditions were not included 
as H2AX activation did not significantly increase and resembled that seen in Figure 3.6. (b) Signal 
intensities were determined and normalised to the untreated control as before. The mean 
normalised intensities and SD values are shown. (c) The type of H2AX signal observed by the 
different experimental and control conditions were determined and the percentage of each type of 
signal calculated. The number of cells in each condition was as follows: -UVA –ATMi: 0 h 105, 24 h 
101; +UVA –ATMi: 0 h 100, 1 h 107, 2 h 110, 4 h 109, 8 h 100, 24 h 100; -UVA +ATMi: 0 h 100, 1 h 
101, 2 h 101, 4 h 101, 24 h 101; +UVA +ATMi: 0 h 100, 1 h 103, 2 h 100, 4 h 100, 24 h 100. 
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at each time point investigated relative to those which received no ATM inhibition (p < 
0.001 for each time). It is important to note that the immunofluorescence data 
presented in figure 3.10 represents that of a single experiment. No duplicate 
experiments in which the same confocal microscope laser settings for laser power 
and gain were used to image both the ATM inhibited and uninhibited UVA 
experimental conditions were conducted. Consequently, confident and accurate 
conclusions cannot be made.  
The type of H2AX signal generated was once again investigated, using the same 
classification system as with figure 3.9a, in order to assess whether ATM inhibition 
had an impact on the type of staining generated. UVA exposure caused the number 
of pan-nuclear stained cells and cells with H2AX foci to increase between cells 
treated with ATMi but received no irradiation and those which received both ATM 
inhibition and UVA exposure (Figure 3.10c). However, the inclusion of ATM inhibition 
did not appear to have an impact on the type of H2AX signal generated following 
UVA exposure relative to cells which received irradiation but no inhibition. However, 
once again, repeat experiments should be conducted. 
 
VII. Analysis of H2AX activation in bystander cells co-cultured with UVA 
irradiated cells over time 
The radiation-induced bystander effect is a phenomenon in which nonirradiated cells 
exhibit the characteristics of irradiated cells, such as apoptosis induction, cytogenic 
damage and DDR activation, as a result of signals received from nearby cells which 
had been irradiated (Nagawa and Little, 1992). The bystander effect has been well 
established for ionising radiation (Rzeszowska-Wolny et al., 2009, Prise et al., 2003) 
and there is also supporting evidence for the ability for both UVB and UVA irradiation 
to induce a bystander effect in nonirradiated cells (Dahle et al., 2005). Here, a similar 
methodology of co-culturing nonirradiated and irradiated HaCaTs used in a number 
of studies was used to analyse H2AX activation in nonirradiated bystander cells 
(Whiteside and McMillan., 2009, Widel et al., 2014).  
Prior to the commencement of this research project, a PhD student in the lab also 
investigated the UVA-induced bystander effect by looking at how H2AX activation 
changes from 24 to 48 h (Steele., 2016). It was observed that H2AX activation 
increased between 24 and 48 h. To investigate this further, an additional co-culture 
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duration of 72 h was included in the present study. HaCaT keratinocytes which were 
to be irradiated were seeded into inserts that possessed a 1 m pore membrane, 
whilst the nonirradiated bystander cells were seeded into wells of six-well plates 
(Figure 2.1). Media supplemented with different components were used for the 
different cell populations. Phenol red can function as a photosensitiser and as a 
result, phenol red free medium was used for the culturing of the irradiated cells. 
Phenol red medium was used for the bystander cells as this media was 
supplemented with antibiotics and would therefore help to prevent infection following 
extended periods of incubation. Following irradiation with UVA, the inserts were 
transferred to the six-well plates containing the bystander cells and incubated 
according to the experimental demands. Immunofluorescence was used to 
investigate how activation of H2AX in the bystander cells changes over time 
following exposure to cells irradiated with 100 kJ m-2 UVA.  
As with the investigations into the role of direct UVA irradiation on the DDR, 
immunofluorescence was used to image bystander cells that had been co-cultured 
with cells that had been irradiated with 100 kJ m-2 UVA for 24, 48 and 72 h (Figure 
3.11a). As before, the intensity of the H2AX signal was measured. The individual 
intensity values were normalised against the mean intensity for the control 24 h 
condition as before. Co-incubation of bystander cells with feeder cells that had not 
been irradiated did not increase H2AX signal intensity with increasing duration of co-
incubation up to 72 h (Figure 3.11b). As a result, it can be concluded that any 
difference seen between the experimental conditions whereby irradiated cells were 
co-cultured with nonirradiated bystander cells is due to signals received from the 
irradiated cells, not due to endogenous damage, which may increase with increased 
co-culture. Whilst H2AX activation was slightly increased following 24 h co-
incubation between irradiated feeder cells and nonirradiated bystander cells, a much 
greater increase in H2AX activation was seen following 48 and 72 h co-culture. 
Signal intensity significantly increased from 24 h to 48 h (p < 0.001) for the irradiated 
experimental groups whilst no difference was seen between 48 and 72 h co-culture 
(p = 0.900). Comparison of signal intensity between each control condition and its 
corresponding experimental condition showed that H2AX activation was significantly 































In addition to the analysis of H2AX activation, the proportion of replicating cells in 
each experimental and control group was also assessed through the use of a Click-iT 
EdU Alexafluor imaging kit. The number of EdU positive cells was not affected by 
increased incubation of bystander cells with non-irradiated feeder cells (Figure 
3.11c). Similarly, the number of EdU positive cells did not increase as the duration of 
co- culture of bystander cells with irradiated cells increased. However, comparison of 
each experimental group with its corresponding control showed that the number of 
cells in S-phase significantly increased for the bystander cells which were co-cultured 
with irradiated cells for 48 h (p = 0.014) and 72 h (p = 0.046). However, no difference 
Figure 3.11. Immunofluorescent analysis of H2AX activation and cell cycle progression in 
bystander cells co-cultured with UVA irradiated cells.  
HaCaT keratinocytes were seeded into the wells of six-well plates containing coverslips at a density 
of 1 x 105 cells/well and into sterile inserts which possess 1 m pore membranes at a density of 
5000 cells/insert. Cells within the inserts were irradiated with 100 kJ m-2 UVA and immediately 
transferred to the wells containing the bystander cells. The appropriate nonirradiated control was 
included. The irradiated cells and bystander cells were co-cultured and incubated for the indicated 
lengths of time. Replicating cells were stained by addition of EdU. The bystander cells were fixed 
and permeabilised as before. (a) Cells were visualised via confocal microscopy and images taken 
using Zen software. (b) Signal intensity values were measured and normalised against the mean 
intensity for the control 24 h condition. The data presented represents the mean and SD for three 
individual experiments. (c) The number of EdU positive cells for the three individual experiments 
was determined and the overall percentage for each condition calculated. (d) The type of signal 
produced by each individual cell was recorded and the overall percentage for each type of staining 
across the three experiments was determined. The number of cells in each condition was as 
follows: Control 24 h 294; 48 h 312; 72 h 349; UVA 100 kJ m-2 24 h 337; 48 h 313; 72 h 318. *p < 
0.05, indicates the significant difference between each experimental condition and its corresponding 





between the number of EdU positive cells was seen for bystander cells co-cultured 
with nonirradiated cells for 24 h and those which were co-cultured for the same 
duration with irradiated feeder cells (p = 0.416). 
The types of H2AX signal produced by co-incubation of nonirradiated bystander 
cells with UVA irradiated feeder cells was also assessed. The same classification 
system as in figure 3.9 was utilised. For each control and experimental condition, the 
most frequent type of H2AX signal recorded was that of pan-nuclear staining (Figure 
3.11d). Whilst it appeared as though the proportion of negatively stained nuclei 
decreased with increased co-culture duration with irradiated feeder cells, no 
significant differences were observed between any of the conditions for this type of 
signal. The proportion of cell nuclei with H2AX foci was not significantly affected by 
the introduction of UVA irradiated feeder cells compared to nonirradiated controls.  
 
VIII. Immunofluorescence analysis of the dose-dependent UVA-induced 
bystander effect  
As well as investigating the effect of the UVA-induced bystander effect over time with 
a fixed dose of UVA, investigations were carried out to determine whether or not the 
UVA-induced bystander effect is dose-dependent. The same experimental design as 
with figure 3.11 was used. Here, feeder cells were irradiated with various doses of 
UVA up to 100 kJ m-2 and were co-cultured with UVA irradiated cells for 48 h before 
fixation, permeabilisation and staining. This co-incubation duration was chosen as   
48 h co-incubation of bystander cells with cells irradiated with 100 kJ m-2 UVA 
represented a significant increase in H2AX activation from 24 h and there was no 
significant difference between 48 and 72 h (Figure 3.11b). As before, 
immunofluorescence was used to image the bystander HaCaTs via confocal 
microscopy (Figure 3.12a). Signal intensity was measured and the individual intensity 
values normalised against the mean intensity calculated for the control condition in 
which feeder cells were not irradiated. The introduction of UVA irradiated feeder cells 
caused H2AX activation to increase above that seen for the control condition with 
significant differences in signal intensity observed for each UVA dose (p < 0.001) 
(Figure 3.12b). This indicates that co-incubation of feeder cells irradiated with 25 kJ 
m-2 UVA is sufficient to activate the DDR in bystander cells as indicated by increased 
H2AX activation above the levels observed in the controls. However, no difference 







































Figure 3.12. Immunofluorescent analysis of H2AX signalling and cell cycle progression in 
bystander cells co-cultured with cells irradiated with various dosages of UVA irradiation.  
HaCaT cells were seeded into the wells of six-well plates and into thincerts as with figure 3.11. Cells 
within the inserts were irradiated with the indicated dosages of UVA irradiation and immediately 
transferred to six-well plates containing nonirradiated bystander cells. They were co-cultured 
together for 48 h before being stained with EdU, fixed, permabilised, and stained with the 
appropriate antibodies required for detection of H2AX as before. (a) Cells were visualised via 
confocal microscopy and images taken using Zen software. (b) The mean signal intensity for the 
control bystander cells was calculated and all individual intensity measurements normalised against 
this value. The mean and SD indicated represent that of three individual experiments. (c) The 
number of EdU positive cells for the three individual experiments was determined and the overall 
percentage for each condition calculated. (d) The type of signal produced by each individual cell 
was recorded and the overall percentage for each type of staining across the three experiments was 
determined. The number of cells in each condition was as follows: Control 312; UVA 25 kJ m-2 350; 
50 kJ m-2 307; 100 kJ m-2 314. *p < 0.05, indicates the significant difference between each 




25 and 100 kJ m-2 conditions). This would suggest that the UVA-induced bystander 
effect is not dose-dependent.  
The number of S-phase cells was again determined through the use of a Click-iT 
EdU AlexaFluor imaging kit. The proportion of EdU positive cells increased between 
the control bystander cells and those which were co-cultured with feeder cells 
irradiated with various UVA doses (Figure 3.12c). Significant differences were 
observed between the control condition and the 25 and 100 kJ m-2 UVA conditions  
(p = 0.014 and p = 0.023, respectively). However, as with H2AX signal intensity, 
increasing the dose of UVA to which the feeder cells were exposed to did not affect 
the proportion of EdU positive cells (p = 0.780 between the 25 and 100 kJ m-2 
experimental conditions). The number of proliferating bystander cells did not increase 
in a dose-dependent manner.  
Similarly, the type of H2AX signal generated in nonirradiated bystander cells 
following co-incubation with UVA feeder cells was unaffected by increasing UVA 
dose (Figure 3.12d). The proportion of pan-nuclear stained cells, nuclei with H2AX 
foci and nuclei which were negatively stained did not change with the introduction of 
UVA irradiated feeder cells compared to nonirradiated controls or with increased 
UVA irradiation.  
 
IX. Investigation of the dose-dependent UVA-induced bystander effect 
with increased co-incubation duration via clonogenic survival 
assays 
Clonogenics survival assays were conducted to further investigate whether or not the 
UVA-induced bystander effect was dose-dependent. As with the other bystander 
experiments, the cells to be irradiated were seeded into inserts and transferred 
immediately following irradiation into the wells of the plates containing the bystander 
cells, which had been seeded at a density of 200 cells/well. 
An additional UVA dose of 12.5 kJ m-2 was included to help determine the threshold 
dose at which the UVA-induced bystander effect is induced as 25 kJ m-2 was shown 
to be sufficient to induce a bystander effect. Following one week co-culture, the 
number of colonies per well was determined and the mean number of colonies from 
triplicate samples determined. Percentage survival was calculated for each 
experimental condition relative to the control condition in which feeder cells were not 
irradiated. Whilst the previous immunofluorescence experiment suggested that the 
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UVA-induced bystander effect is not dose-dependent, the results from the 
clonogenics survival assays inferred the opposite, that the UVA-induced bystander 
effect is dose-dependent. As UVA dose increased, the survival of the bystander cells 
relative to the controls decreased (Figure 3.13). Significant decreases in survival 
relative to the control were observed for bystander cells that were co-cultured with 
feeder cells irradiated with 25 kJ m-2 (p < 0.05) and 50 and 100 kJ m-2 UVA (p < 
0.01). Significant differences in survival were also seen between the 12.5 kJ m-2 
experimental conditions and all other experimental conditions (p < 0.01), between 25 



































Figure 3.13. Clonogenic survival assay investigating the effect of various dosages of UVA on 
the UVA-induced bystander effect.    
HaCaT keratinocytes were seeded into the wells of six-well plates at a density of 200 cells/well and 
into thincerts which possess 1 m pore membranes at a density of 5000 cells/insert. Cells within the 
inserts were irradiated with various dosages of UVA and immediately transferred to the wells 
containing the bystander cells. The appropriate nonirradiated control was included. The irradiated 
cells and bystander cells were co-cultured and incubated for seven days. The resulting colonies 
were fixed and stained with Giemsa. The mean number of colonies for each treatment from triplicate 
samples was determined and the mean percentage survival calculated relative to untreated 
controls. The data shown represents the mean and SD survival from three individual experiments. 
*p < 0.05, indicates the significant difference between each experimental condition and the control 






DNA damage surveillance and repair pathways play an important role in protecting 
skin cells against the carcinogenic effects of ultraviolet radiation. This is exemplified 
by the thousand fold increased risk of developing skin cancer in patients with the 
inherited syndrome Xeroderma pigmentosum in which patients have defective 
nucleotide excision repair. The major source of ultraviolet radiation to which we are 
exposed to is solar radiation, and whilst UVR is composed of three wavebands, UVC, 
UVB and UVA, 90-95% of terrestrial UVR that we are exposed to is UVA with the 
remainder being UVB. This is due to the capacity for the ozone layer to absorb all of 
the UVC waveband and the vast majority of the UVB waveband. Both UVB and UVA 
cause damage to DNA, as well as other cellular biomolecules, but the theoretical 
mechanisms proposed for each differ. Whilst a direct mechanism is accepted for 
UVB, both indirect and direct mechanisms have been proposed for UVA. Although 
UVA makes up the majority of the UVR we are exposed to, it is relatively 
understudied in comparison to UVB. In particular, the impact of UVA exposure on the 
initiation of the DNA damage response remains to be fully understood. In the present 
study, the effect of UVA irradiation on the DDR was studied. A number of techniques 
were employed to analyse the different aspects of the DDR following both direct 
irradiation with UVA, and also in bystander cells which, although they had not been 
irradiated themselves, had been co-cultured with feeder cells which had been. The 
dynamics of the DDR response was studied in terms of how activation of key 
components of the vital signalling pathway changes over time and how inhibition of 
certain components impacts the response.  
 
I. UVA irradiation induces a dose-dependent decrease in cell survival 
in HaCaT keratinocytes 
In the past, it was believed that, although making up the majority of terrestrial UVR, 
that UVA was far less carcinogenic and harmful than UVB irradiation. This is 
exemplified by the majority of sunbeds in the past emitting less UVB and therefore 
more UVA, as the dangers of UVA were understudied (WWW, WHO | Sunbeds). 
However, as the amount of research into the harmful effects of UVA increased, it 
became increasingly apparent that exposure to UVA alone can generate the same 
mutational fingerprint consisting of pyrimidine dimers as UVB (Ikehata et al., 2008). 
Consequently, in 2009, the full spectrum of UVR was categorised as being 
carcinogenic to humans (El Ghissassi et al., 2009). In this present study, the first 
experiment conducted confirmed the detrimental effects of UVA on cell viability. 
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HaCaT keratinocytes exposed to UVA (up to 100 kJ m-2) experienced decreased cell 
survival in a dose-dependent manner (Figure 3.1). This observation was consistent 
with a number of previous reports (He et al., 2016, Hwang et al., 2011). The dose-
dependent decrease in cell viability is unsurprising as numerous studies have 
described different types of lesions that can be generated by UVA. Although the 
mechanisms by which they arise are unclear, UVA has been shown to be able to 
generate CPDs, which lead to the generation of oxidised bases and DSBs (Mouret et 
al., 2005, Cadet et al., 2015, Rapp and Greulich, 2004). Each of these lesions are 
detected by DNA damage sensors, which consequently leads to the activation of the 
DDR, which ultimately, through the propagation of a signalling cascade, brings about 
cell cycle arrest so that repair of these lesions can take place. In the event that the 
damage cannot be repaired, cells are directed to enter senescence or undergo 
apoptosis. It would therefore be expected that as UVA exposure increases, so do the 
number of generated lesions and as a result, increased numbers of cells enter 
apoptosis to avoid replication with a modified genome. 
 
II. Inhibition of ATM and ATR caused decreased cell viability following 
irradiation with 50 kJ m-2 UVA 
Different types of lesions generated by genotoxic agents, including UVA, are 
detected by different DNA damage sensors. Whilst the MRN complex recognises 
DSBs, the 9-1-1 complex and RPA cooperate to detect stalled replication forks. 
Activation of these damage sensors leads to the recruitment and activation of the 
apical kinases ATM and ATR, respectively, which propagate the DNA damage signal 
to bring about the actions of the DDR. The different arms of the DDR were evaluated 
in context of UVA irradiation by the independent inhibition of ATM and ATR. The 
apical kinase inhibitors used, KU-60019 (ATMi) and VE-821 (ATRi), have been 
shown to be highly selective and specific for their targets with minimal cross-reactivity 
against related PIKKs, which include each other, DNA-PK, mTOR and PI3K. VE-821 
had very little cross-reactivity with these related PIKKs at the concentrations used 
and KU-60019 is an improved inhibitor for ATM in comparison to KU-55933 and too 
has very little activity against similar PIKKs at the concentrations used in the present 
study (Reaper et al., 2011, Golding et al., 2009). A UVA irradiation dosage of 50 kJ 





In the absence of irradiation with UVA, pre-treatment with ATMi and ATRi at each 
concentration did not decrease cell survival (Figure 3.2). However, independent 
inhibition of ATM and ATR both caused decreased cell survival in a dose-dependent 
manner in conjunction with exposure to 50 kJ m-2 UVA (Figure 3.3). This would 
suggest that both ATM and ATR and their downstream targets are required in 
processing lesions generated by UVA. This is consistent with evidence that Chk2 and 
Chk1 are phosphorylated by ATM and ATR, respectively, following exposure to UVA 
irradiation (Di Siena et al., 2013, Girard et al., 2008, Zhang et al., 2002). The 
importance of both ATM and ATR in responding to damage generated following UVA 
irradiation is also consistent with evidence that both apical kinases are required for 
DDR activation following exposure to ionising radiation (Cui et al., 2014).  
Inhibition of ATR prevents phosphorylation of Chk1 following the detection of stalled 
replication forks and therefore prevents the activation of CDC25 and other 
downstream effectors. ATR is recruited to stalled replication forks at regions of 
ssDNA, which are subsequently coated in RPA. ATR is recruited to ssDNA regions 
generated during the processing of bulky lesions such as CPDs and 64PPs (Batista 
et al., 2009). It has been demonstrated that ATM and the nuclease activity of the 
Mre11 component of the MRN complex are required for the processing of DSBs to 
generate regions of ssDNA that can then be coated with RPA to allow for the 
recruitment of ATR (Jazayeri et al., 2006). Although ATM is inhibited (Figure 3.3a), 
the MRN complex is able to generate ssDNA regions that can be recognised by the 
ATR arm of the DDR. The importance of ATR in bringing about checkpoint arrest and 
cell survival following DNA damage is highlighted by the fact that multiple tumour 
types frequently possess an ATM deficiency through ATM mutations or epigenetic 
downregulation (Greenman et al., 2007).  
ATR inhibition caused a dose-dependent decrease in combination with exposure to 
50 kJ m-2 UVA, with no significant differences seen in cell survival between cells pre-
treated with 0.2 and 1 M ATRi (Figure 3.3b). However, even at the highest 
concentration used, there was still over 40% survival. This may be due to the fact 
that ATM is still available to propagate the DNA damage signal from the activated 
MRN complex to numerous downstream effectors so that repair can occur. UVA has 
been shown to be able to generate DSBs with the proposed mechanism being 
through the repair of clustered oxidative DNA damage (Rapp and Greulich, 2004, 
Greinert et al. 2012). As a result, ATM-mediated repair following its activation by the 
MRN complex following recognition of DSBs would explain why ATR inhibition does 
not result in the complete loss of repair of UVA-induced lesions. 
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III. Inhibition of ATM, ATR and other DNA damage response 
components did not decrease cell viability at a higher dose of UVA 
In order to investigate the role of other DDR components in responding to UVA-
induced DNA damage, additional cell viability assays were conducted. The more 
robust XTT cell viability assay was used to investigate how inhibition of additional 
components of the DDR affected cell viability following UVA exposure. During the 
process of performing the MTT assay, prior to the addition of DMSO in order to 
dissolve the formazan crystal within each well, the media is carefully removed. This 
can cause issues as the removal of the media can displace crystals and lead to the 
resulting readings being lower than they should be, providing false negative results. 
The XTT cell viability assay presents a more robust method for measuring cell 
survival as this assay skips the requirement of carefully removing the media prior to 
detection.  
Using the XTT assay, the inhibition of additional components was investigated in 
relation to cell survival following exposure to UVA irradiation. These inhibitors 
included a PI3K inhibitor (PI3Ki) and a MRN inhibitor (mirin). Mirin was included to 
investigate how preventing detection of DSBs impacted cell viability following UVA 
exposure. PI3Ks regulate cellular signalling networks involved in processes such as 
survival, growth, and cell cycle regulation as part of the PI3K/AKT/mTOR pathway 
(Gharbi et al., 2007). This pathway is linked with protecting cells from apoptosis and 
UVA has been demonstrated to, although not as effectively as UVB, lead to 
increased expression of PI3Kp85, a regulatory subunit of PI3K (Syed et al., 2012). It 
would therefore be expected that inhibition of this pathway would lead to decreased 
cell survival. 
In this experiment, the UVA dose was increased to 100 kJ m-2 in order to better 
reflect UVA exposure that is environmentally relevant. This dose reflects an hour’s 
exposure in subtropical regions in the summer months (Whiteside and McMillan, 
2009). There was consistency with the previous MTT assays in that DDR component 
inhibition did not impact cell survival in the absence of UVA irradiation. However, the 
synergy between UVA and independent inhibition of ATM or ATR were not 
reproduced. Whilst pre-treatment with 200 nM ATMi and ATRi caused a significant 
decrease in cell survival following exposure to 50 kJ m-2 UVA, the same decrease did 
not occur once the UVA dose increased (Figure 3.4). 
Similarly, PI3K inhibition and MRN inhibition did not decrease cell survival relative to 
the irradiated, uninhibited control. This may have occurred as a result of increasing 
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the dose of UVA to which the cells were exposed to. As shown in the absence of any 
inhibition, an increase of 50 to 100 kJ m-2 UVA resulted in a significant decrease in 
cell survival, likely as a result of increased lesions generation. Perhaps exposure to 
50 kJ m-2 in the absence of DDR component inhibition generated lesions that could 
be repaired efficiently without the requirement of apoptosis induction. Inhibition of 
ATM or ATR may then have prevented these lesions from being repaired efficiently, 
resulting in decreased cell survival. Conversely, the increased lesions generated 
following exposure to 100 kJ m-2 in the absence of DDR component inhibition may 
have been unrepairable and as a result the DDR induced apoptosis and senescence. 
Possible supporting evidence for this explanation was provided by a PhD student 
working in the same lab in which the present study was completed. Here, changes in 
mitochondrial membrane potential were measured in order to study apoptosis 
induction following UVA irradiation. Mitochondrial membrane depolarisation was seen 
within 1 h of irradiation with 100 kJ m-2 UVA, a duration which is not long enough for 
the p53 axis of the DDR to exert its effect (Steel, 2016). This could potentially explain 
why DDR inhibition was then unable to decrease cell viability above that seen in the 
absence of inhibition. An appropriate future experiment would be to therefore 
investigate how varying the UVA dose to which cells are exposed to following pre-
treatment with inhibitors against DDR components impacts cell survival.  
Cui et al. (2014) demonstrated that ATM and ATR are both required for responding to 
damage induced by ionising radiation as, while depletion of one apical kinase alone 
had little effect on cell cycle arrest, depletion of ATR in ATM-deficient cells caused 
severe G2/M checkpoint attenuation and increased lethality. Consequently, similar 
studies should be carried out to investigate how inhibition of both ATM and ATR 
impacts cell survival following UVA irradiation and to provide further insight into the 
involvement of other PIKKs such as DNA-PKcs and the involvement of PI3K in DDR 
activation following UVA exposure. Additionally, future experiments should also 
investigate how different combinations of inhibition impact cell survival. For example, 
it has been demonstrated that the Mre11 component of the MRN complex possesses 
nuclease activity which can generate ssDNA regions that can then be coated by 
RPA, allowing for the recruitment and activation of ATR. It would be interesting to see 
how inhibition of the MRN complex and ATR at the same time impacts the DDR 
following UVA exposure. 
Both cell viability assays used in the present study work by measuring the reduction 
of tetrazolium salts (Abe and Matsuki, 2000, Roehm et al., 1991). The two 
colorimetric assays both measure cell viability and proliferation by measuring the 
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capacity of mitochondrial enzymes present in living cells to reduce the salts. The 
amount of formazan product can then be measured using a spectrophotometer. The 
use of metabolic activity as a surrogate for cell viability incurs problems as resting 
cells may have low metabolic activity, leading to an underestimation of cell survival, 
whilst dying cells may still possess some activity, leading to an overestimation. 
Future work investigating the role of DDR component inhibition in the context of UVA 
should also consider using alternative methods for assessing cell viability, such as 
methods that measure rates of apoptosis, including TUNEL assays to measure DNA 
fragmentation and using Annexin V to measure phosphatidyl serine externalisation. 
In particular, future experiments should assess how inhibiting both ATM and ATR 
impacts cell viability as data in the present study suggests that both are involved in 
responding to damage generated following UVA irradiation.  
In addition to investigating the role of direct UVA exposure on cell viability, the effect 
of direct UVA irradiation was further analysed by western blot and 
immunofluorescence to assess how activation of different components of the DDR 
change over time following irradiation. Once again, 100 kJ m-2 UVA was used as it is 
an environmentally relevant dose.  
 
IV. Western blot analysis found H2AX activation to peak at 1 and 2 h 
following irradiation with 100 kJ m-2 UVA 
H2AX has been well-established as an effective biomarker for DNA damage and 
has also been shown to be an accurate biomarker for detecting damage generated 
by UVA exposure both in vitro in both keratinocyte cell culture and within an artificial 
epidermis and also in vivo in human skin (Cleaver, 2011, Kuo et al., 2008, Barnes et 
al., 2010). There is also controversy in past research regarding the ability of UVA to 
induce H2AX phosphorylation at Ser139 to yield H2AX. For example, Rizzo et al. 
(2011) studied DSB-formation in primary skin fibroblasts following exposure to 
various dosages of UVA and found that UVA irradiation did not cause H2AX nuclear 
foci formation. Similarly, UVA up to 50 kJ m-2 alone was found to be incapable of 
inducing H2AX activation, although treatment with the photosensitiser 8-
methoxypsoralen (8-MOP) in combination with UVA exposure was able to induce the 
production of H2AX (Toyooka et al., 2011). However, numerous other studies have 
found that UVA irradiation can induceH2AX formation (Lu et al., 2006, Rapp and 
Greulich, 2004). The data in the present study are consistent with these latter studies 
81 
 
as irradiation with 100 kJ m-2 UVA resulted in H2AX activation, as indicated by both 
western blot analysis and immunofluorescence.  
In conjunction with this study, another study undertaken in the lab looked at H2AX 
activation at 0, 1, 3 and 24 h post-irradiation, where activation peaked at 1 h, 
remained present at 3 h and was abrogated by 24 h (Steel, 2016). However, there is 
a large window of 21 h unaccounted for. Here, additional time points were 
investigated including 2, 4, 8 and 16 h post-exposure, with peak activation seen 
between 1 and 2 h post exposure to UVA (Figure 3.5). Western blot data indicated 
that H2AX was still present 16 h following irradiation. The increased H2AX 
activation over this period of time is likely as a result of the positive feedback loop 
that is generated in order to extend H2AX phosphorylation to the megabase 
chromatin region flanking the lesion (Rogakou et al., 1999). This provides a docking 
site for DNA repair factors and forms visible H2AX immunofluorescent foci. The 
positive feedback loop arises as a result of MDC1 recruitment following initial 
phosphorylation of H2AX. MDC1 is then phosphorylated by casein kinase 2 (CK2), 
which promotes phosphorylation-dependent interactions with NBS1, which is a 
component of the MRN complex. This leads to increased activation of the MRN 
complex, which results in increased ATM activation and therefore increased H2AX 
phosphorylation (Kinner et al., 2008). In the data presented in Figure 3.5, H2AX 
activation was also observed in the wildtype control condition at 24 h, in which the 
cells received no irradiation. This observation was absent in the repeat experiments.  
 
V. Immunofluorescence was used to further quantify H2AX activation 
following irradiation with 100 kJ m-2 UVA 
Immunofluorescent analysis of H2AX signalling was utilised to quantify H2AX 
activation over time following UVA exposure and served to support the evidence 
provided by western blot. Here, H2AX activation was again elevated at 1 and 2 h 
post UVA exposure but similar levels of H2AX activation were also present at 4 h 
post irradiation (Figure 3.8). In addition to providing information on the amount of 
H2AX phosphorylation, immunofluorescence was used to record the type of H2AX 
signal generated. Three types of signal were recorded, pan-nuclear staining, H2AX 
foci and negative, in which nuclei were neither pan-stained nor presented foci (Figure 
3.9a). Direct UVA irradiation resulted in increased pan-nuclear staining and 
increased numbers of nuclei with H2AX foci (figure 3.9b). Pan-nuclear staining 
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peaked at 1 and 2 h post-irradiation whilst foci generation peaks at 1, 2 and 4 h post-
irradiation. As mentioned previously, an aspect of the DDR is a positive feedback 
loop to amplify H2AX phosphorylation to megabase regions of chromatin to provide a 
region for repair factors to interact with. This process has been shown by numerous 
studies to produce immunofluorescent foci in mammals following induction of DNA 
damage from a number of sources. It is therefore highly likely that the increase in 
H2AX foci seen between 1 and 4 h post-irradiation is a result of this positive 
feedback loop, generated to provide a platform for repair factors to repair lesions 
generated by UVA exposure.  
Similarly, the induction of pan-nuclear H2AX signals have been demonstrated for 
numerous DNA damaging agents, including IR and UVR (Ding et al., 2016, Meyer et 
al., 2013). Meyer et al. (2013) suggest that pan-nuclear staining occurs as a result of 
H2AX phosphorylation in undamaged chromatin over the entire nucleus and does not 
elicit a full pan-nuclear DDR. They found that the pan-nuclear H2AX signal is 
mediated by the kinases ATM and DNA-PK and they suggest that the pan-nuclear 
response depends on the amount of DNA damage. Ding et al. (2016) provided 
further insight into the role of pan-nuclear H2AX staining, suggesting that the pan-
nuclear response represents an apoptotic signal, again triggered by ATM and DNA-
PKcs activation. Conversely, pan-nuclear H2AX signalling has also been shown to 
have no effect on cell survival following UV irradiation (Revet et al., 2011).  
The use of additional time points allows for the investigation of how phosphorylation 
of H2AX to generate H2AX changes over time and may provide insight into the 
types of damage UVA induces as H2AX activation is regarded as an early event 
following the production of DSBs (Barnes et al., 2010). The increase up to 1 and 2 h 
post-irradiation with 100 kJ m-2 was inconsistent with results generated by Lu et al. 
(2006) in which treatment with 80 kJ m-2 UVA caused increased phosphorylation of 
H2AX at Ser139 in a time-dependent manner with H2AX levels increasing up to 6 h 
post-irradiation. A similar dynamic in H2AX activation to the present study was seen 
following UVB exposure that caused increased levels of H2AX in the initial couple of 
hours following irradiation, with peak activation 0.5 h following irradiation (which was 
not investigated here) (Scarpato et al., 2013). However, in this study, basal levels of 
H2AX were restored 5 h post-UVB exposure, not 24 h as with UVA here. UVB 
irradiation leads to the generation of pyrimidine dimers and UVA has been shown to 
generate CPDs, although not 64PPs and irradiation with 100 kJ m-2 UVA has been 
shown to induce similar levels of CPDs as high doses of UVB (0.6 kJ m-2) (Murray et 
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al., 2016). It is therefore possible that the persistence of H2AX activation is due to 
increased time required to repair UVA induced damage, such as DSBs and oxidative 
damage. The role of UVA-induced CPDs in initiating the DDR and leading to H2AX 
activation cannot be ignored however as areas positive for CPDs have been shown 
to co-localised with H2AX (Oh et al., 2011). Additionally, UVA-induced DSB 
formation and ROS-mediated damage as a result of UVA exposure have also both 
been shown to result in H2AX activation (Calo et al., 2015, Greinert et al., 2012). 
Further investigations into how repair of the different types of lesions that UVA has 
been shown to generate should be conducted to provide insight into how the different 
pathways of the DDR cooperate to repair the different lesions.  
 
VI. Phosphorylation of Chk2 peaked immediately following UVA 
exposure and was unchanged following the introduction of ATM 
inhibition 
Western blot analysis was also used to investigate how Chk2 phosphorylation 
changes over time following direct UVA irradiation. Chk2 phosphorylation peaks at    
0 h and gradually decreases from there (figure 3.5). Chk2 is phosphorylated and 
activated by ATM following activation of the apical kinase by the MRN complex. This 
finding is indicative that repair of UVA damage, is, at least in part, ATM dependent. 
This is consistent with the cell viability data in the present study and with previous 
studies that UVA irradiation produces damage that is repaired following ATM 
activation. A similar peak in Chk2 phosphorylation was reported by Girard et al. 
(2008) following exposure of MRC5Vi cells to 80 kJ m-2 UVA.  
Following this, the dynamics of H2AX and p-Chk2 activation were assessed with the 
addition of an ATMi pre-treatment. The impact of ATM inhibition on H2AX and Chk2 
phosphorylation was studied by both western blot and immunofluorescence. Cells 
were pre-treated with 200 nM ATMi as the compound has very little cross-reactivity 
with other PIKKs at this concentration and was far and above the IC50 for the 
compound. As before, 100 kJ m-2 UVA was used to induce DNA damage and DDR 
activation measured at different times post-irradiation. H2AX activation shifted with 
decreased levels seen at 1 h and increased activation levels now at 2 and 4 h post-
irradiation (Figure 3.6). However, Chk2 is a downstream target of ATM and so it 
would be expected that ATM inhibition would too cause decreased phosphorylation 
of this target. Girard et al. (2008) investigated Chk2 phosphorylation in ATM deficient 
cells and found that activation of this target did not occur at 2 h post-irradiation with 
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80 kJ m-2 UVA. Although this is also seen in the present study, the study did not 
investigate activation immediately following irradiation. The result therefore suggests 
that UVA-induced p-Chk2 activation may not be entirely ATM-dependent and so the 
role of other DDR components such as ATR and PI3K needs to be considered.  
Crosstalk between the ATM-Chk2 and ATR-Chk1 pathways is limited but it has been 
demonstrated that Chk2 can function as a target for ATR in response to ionising and 
ultraviolet irradiation (Wang et al., 2006). Additional replicates should be completed 
as only two sets of data showed this delay in H2AX activation whilst p-Chk2 
activation was unaffected.  
ATM and ATR are both PI-3 Kinase-related kinase (PIKK) family members, which 
have sequence similarity to phosphatidylinositol-3 kinases (PI3Ks) (Falck et al., 
2005). Another member of this family includes DNA-dependent protein kinase 
catalytic subunit (DNA-PKcs) and this has also been shown to be able to 
phosphorylate Chk2 (Zannini et al., 2014, Li and Stern, 2005). DNA-PKcs plays an 
important role in DSB repair, particularly in NHEJ (Shrivastav et al., 2008). ATM 
deficient cells have been shown to display strong dependence on DNA-PKcs to 
repair DSBs and pharmacological or genetic abrogation of DNA-PKcs in ATM-
defective cells has been shown to lead to the accumulation of DSBs and subsequent 
generation of ssDNA regions that are subsequently repaired by the RPA/ATR/Chk1 
axis of the DDR (Riabinska et al., 2013). Perhaps the lack of a delay in p-Chk2 
activation is due to DNA-PKcs compensating for the loss of ATM following the 
introduction of DNA lesions by UVA irradiation? The apparent temporal decoupling of 
H2AX and Chk2 phosphorylation following UVA exposure should be further 
investigated in future research through the use of pan-PIKK inhibitors as well as 
individual inhibition of ATM, ATR and DNA-PKcs and combined treatments where 
different combinations are inhibited. This would allow investigation into how the DDR 
is initiated following UVA exposure and may provide insight into the different types of 
lesion generated by UVA are repaired.  
 
VII. H2AX activation decreased following ATM inhibition in UVA 
irradiated HaCaTs 
H2AX activation following ATM inhibition was assessed via immunofluorescence.  
The delay in peak H2AX activation seen in the western blot analysis (Figure 3.6) 
was not seen following immunofluorescence analysis, but reduced H2AX activation 
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relative to that seen for uninhibited, UVA irradiated cells was observed (Figure 3.10). 
This would be expected for the similar reasons as mentioned previously. As ATM is 
inhibited, one of the pathways within the DDR is downregulated and so there is 
reduced repair of the UVA-induced lesions, as indicated by the reduced H2AX 
activation. However, ATR remains active and so H2AX can still be generated and 
ssDNA regions generated by the MRN complex can be repaired in an ATR-
dependent manner (Di Siena et al., 2013). The discrepancy in H2AX activation seen 
between the Western blot analysis and immunofluorescence data needs to be 
considered. The intensity data presented in figure 3.10 represents that of a single 
experiment. Due to time limitations, no duplicate experiments in which the same 
confocal microscope laser settings for laser power and gain were used to image both 
the ATM inhibited and uninhibited UVA experimental conditions were conducted. 
Additional experiments must be completed to further determine how H2AX activation 
changes following ATM inhibition of UVA irradiated cells and to help determine why 
the shift in H2AX activation was not seen for the immunofluorescence data.  
The type of H2AX signal produced was also investigated in the context of ATM 
inhibition. As mentioned previously, H2AX foci over megabase regions arise from a 
positive feedback loop in which MDC1 recruited to the area interacts with NBS1 of 
the MRN complex in a CK2-dependent manner. This results in increased ATM 
activation, leading to increase H2AX phosphorylation at Ser139. It would therefore be 
expected that as ATM is downregulated by pre-treatment with ATMi, that the number 
of cells with H2AX foci would be decreased. In this investigation, the highest 
proportion of cells with H2AX foci was seen for cells that were not pre-treated with 
ATMi and were fixed 1 h following UVA exposure. Populations fixed 1 h post-
irradiation that received ATM inhibition had decreased numbers of cells positive for 
H2AX foci as would be expected and similar effects were seen between the two 
experimental conditions at 2 and 4 h post-irradiation. Interestingly, the number of 
foci-positive cells was elevated for the ATM inhibited condition that were fixed 24 h 
post-irradiation. However, the data presented only came from one individual 
experiment in which images were taken for both the uninhibited and ATMi pre-treated 
experimental conditions with the same confocal microscope settings. Consequently, 
confident conclusion cannot be reached and additional repeats are required to 
assess whether this data is reliable and if the differences seen are significant.  
Furthermore, pan-nuclear H2AX signalling has been shown to be ATM and DNA-
PKcs dependent (Meyer et al. 2013). As a result, it would be anticipated that DNA-
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PKcs-mediated pan-nuclear staining would be able to compensate for the loss of 
ATM. Whilst the proportion of cells that were pan-stained appeared to be similar for 
each experimental condition at each time point, additional repeats would again be 
required.  
The impact of direct UVA irradiation on DDR initiation was only investigated in the 
context of how inhibition of ATM impacts the repair process. Whilst it was expected 
that the observed decrease in H2AX activation would occur following ATM inhibition, 
additional research should be completed to investigate why a shift in peak activation 
was observed when Western blot analysis was carried out. Furthermore, ATM 
inhibition did not cause a delay in p-Chk2 activation. Whilst it is possible that this 
occurred due to DNA-PKcs activity, there is no direct supporting evidence for its 
involvement in Chk2 phosphorylation following UVA exposure. As a result, research 
should be conducted to assess how DNA-PKcs inhibition compares and how 
inhibition of both DNA-PKcs and ATM contributes to Chk2 phosphorylation. 
Activation of other DDR pathway components should be investigated in the context of 
UVA irradiation both in the absence of inhibition and with individual and combined 
inhibition of different DDR components. In particular, there is evidence that UVA 
induced lesions detected by the MRN complex can be processed into ssDNA regions 
by the Mre11 component. Investigations should be conducted to see how ATR-
dependent phosphorylation of H2AX and Chk1 occurs following direct UVA 
irradiation. The impact of inhibiting various components both independently and 
together on H2AX foci generation should also be investigated. One of the outcomes 
of the DDR is to bring about cell cycle arrest. Therefore, cell cycle progression 
following UVA irradiation should be studied in order to analyse the stage of the cell 
cycle in which progression is stalled. This could be done by immunofluorescence via 
labelling techniques such as with EdU as in the bystander portion of the present 
study, or alternatively through flow cytometry. Alternatively, western blot analysis 
could be used to monitor the expression levels of different cyclins.  
 
VIII. H2AX activation increases in bystander cells co-cultured with UVA 
irradiated HaCaTs 
The radiation-induced bystander effect has been well-established for ionising 
radiation (Rzeszowska-Wolny et al., 2009, Prise et al., 2003) and there is also 
evidence that UVB and UVA can too induce a bystander effect (Whiteside and 
McMillan, 2009). In the past, the UVA-induced bystander effect has been studied 
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using models that involve co-culturing irradiated feeder cells with nonirradiated 
bystander cells in a two-chamber system, as in the present study, or through 
culturing bystander cells with medium from which irradiated feeder cells had 
previously been cultured (Redmond et al., 2014, Nishiura et al., 2012, Whiteside et 
al., 2011, Whiteside and McMillan, 2009). This allowed for the study of interactions 
between the differentially treated cell populations in the absence of direct cell-to-cell 
contact. The diffusible species released by the irradiated cells are able to traverse 
the membrane of the transwell insert (Chakraborty et al., 2009). The inclusion of 
appropriate controls whereby feeder cells received no irradiation prior to co-
incubation with the bystander cells demonstrates this as these bystander cells 
experienced no increase in DDR activation as opposed to those co-cultured with 
irradiated cells. Whilst previous studies investigating the UVA-induced bystander 
effect used clonogenic survival assays and techniques to measure ROS generation 
in the bystander cells, the present study assessed the effect via assessment of 
H2AX activation to analyse DDR initiation, which has not previously been 
conducted. Using this method, it was once again confirmed that UVA can induce a 
bystander effect.  
Immunofluorescence was used to assess DDR initation in bystander cells following 
co-cultured incubation with irradiated feeder cells. The UVA-induced bystander effect 
was investigated in terms of how DDR initiation changes over time following 
irradiation of feeder cells with 100 kJ m-2 UVA, which has previously been 
demonstrated to be able to induce the bystander effect (Whiteside and McMillan, 
2009). Co-incubation of bystander cells with feeder cells that had not been irradiated 
with UVA did not increase H2AX intensity with increasing duration of co-incubation 
up to 72 h (Figure 3.11b). Consequently, any difference between the experimental 
groups in which nonirradiated bystander cells were co-cultured with irradiated cells 
and the control conditions is due to signals received from the irradiated cells, not due 
to endogenous damage, which may increase with increased co-culture duration. The 
experiment conducted in the present study follows on from that conducted by Steel 
(2016), where H2AX activation in the context of the UVA induced bystander effect 
was investigated at 24 and 48 h. The present study investigated the same co-culture 
durations as well as an addition duration of 72 h. Activation of H2AX increased at 
each time point for the experimental groups relative to their corresponding untreated 
controls (24, 48, 72 h) as determined by signal intensity normalised to the mean of 
the control 24 h condition. The increase seen at 24 and 48 h was consistent with that 
seen by Steel (2016). Only a slight increase in H2AX signal intensity was seen 
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following 24 h co-incubation between irradiated feeder cells and nonirradiated 
bystander cells. A much greater increase was seen following 48 and 72 h co-
incubation. Whilst a significant increase was seen between the 24 and 48 h 
experimental conditions, no differences was seen between 48 and 72 h.  
Using a similar co-culture model, Whiteside et al. (2011) investigated the timeframes 
of UVA-induced bystander effects using clonogenic survival assays. Here, they 
reported that UVA irradiated cells do not release signals that induce a bystander 
effect immediately and that there is a time lag of over 24 h before levels are sufficient 
to induce an effect. This may account for the lower, although increased activation of 
H2AX. Although the signals released at 24 h are sufficient to cause an increase in 
DNA damage and induce the bystander effect, signals are continuously released 
from the irradiated cells after this point. This would explain why H2AX activation 
continues to increase until 48 h, as more signals are being released. This has 
significant importance as cells directly irradiated with 100 kJ m-2 UVA show a return 
to basal levels of H2AX activation 24 h following irradiation, suggesting that repair of 
generated lesions has taken place. Despite this, data presented here and in previous 
studies indicate that a single exposure to UVA can exert an effect for several days 
following UVA irradiation with the same dosage, therefore amplifying the deleterious 
effects of UVA exposure. A possible avenue for future research could be to 
investigate how the rate at which signals are released from the irradiation changes 
over time. For example, following the initial 24 h lag, does signal release increase for 
a set period of time or not? Consequently, an investigation could be designed to 
compare the bystander effect following 24 and 48 h co-culture with 24 h co-culture of 
bystander cells followed by 24 h in the absence of co-incubation with the irradiated 
cells. Furthermore, Whiteside et al. (2011) demonstrated that signals released by the 
UVA irradiated cells persists for a minimum of three days. Therefore, future 
experiments could assess DDR activation passed the 72 h examined in this study. 
The effect of the UVA-induced bystander effect on S-phase entry was also 
investigated. The duration of co-incubation with UVA irradiated cells had no effect on 
the number of EdU positive cells but the number of EdU positive cells at each time 
did increase for the bystander cells co-cultured with irradiated cells in comparison to 
those which had not been irradiated (Figure 3.11b). One possibility as to why 
bystander cells exposed to damaging signals released by UVA irradiated cells has 
increased EdU incorporation is that the received signals cause slowed progression 
through S-phase. Dardalhon et al. (2008), using Schizosaccharomyces pombe as a 
model organism, found that UVA irradiation of S phase cells slows down DNA 
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replication in a checkpoint independent manner. It is important to consider that this 
study focused on direct irradiation rather than the UV-induced bystander effect. 
Furthermore, the ability to apply the findings for S. pombe to mammalian cell types is 
unclear. Alternative possibilities as to why there was increased numbers of EdU 
positive cells for the experimental bystander groups could be that the damaging 
signals received by the bystander cells caused decreased exiting from S-phase or 
increased entry. It would be interesting to see how the number of EdU positive cells 
changes within a synchronised population of bystander cells. The increase in the 
number of EdU positive cells seen in the UVA-induced bystander effect should be 
compared to the effect of direct UVA irradiation.  
The type of H2AX signal generated by the UVA-induced bystander effect was also 
studied. Pan-nuclear staining was the predominant type of H2AX signal for both the 
control and UVA conditions (Figure 3.11d). Whilst it appeared as though H2AX foci 
numbers were increasing as co-culture duration increased, no significant differences 
were seen among the experimental groups and between the UVA treated conditions 
and their corresponding control groups. Meyer et al. (2013) found that pan-nuclear 
H2AX signalling is dependent on the amount of induced DNA damage. As the 
proportion of pan-nuclear stained bystander cells co-cultured with irradiated cells 
appeared to increase for 48 h co-incubation in comparison to 24 h, it is possible that 
the bystander cells fixed after 48 h possess more lesions. This theory would be 
consistent with the elevation of H2AX activation seen via analysis of signal intensity. 
 
IX. The UVA induced bystander effect is not dose-dependent following 
48 h co-culture incubation 
In addition to investigating how the UVA induced bystander effect changes over time, 
the effect of different doses of UVA were also studied. Here, feeder cells were 
irradiated with various doses of UVA up to 100 kJ m-2 and co-incubated with 
nonirradiated bystander cells for 48 h. This duration was chosen as it produced the 
largest increase in H2AX activation in the previous experiment. The present study 
has demonstrated that direct UVA irradiation causes dose-dependent toxicity and this 
observation has been supported by numerous studies, including Redmond et al. 
(2014) who demonstrated this in primary human melanoncytes, fibroblasts and 
keratinocytes. However, past research has found that the ionising radiation-induced 
bystander effect does not follow a dose-dependent response (Kadhim et al., 2013, 
Rzeszowska-Wolny et al., 2009, Belyakov et al., 2001). Similar to these findings, the 
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present study found that the UVA-induced bystander effect is not dose-dependent 
following 48 h co-culture incubation (Figure 3.12b). 
The lack of a dose-dependent increase in the UVA-bystander effect following 48 h 
co-incubation could be due to there being a maximum amount of signals that can be 
released from the UVA irradiated cells. 25 kJ m-2 UVA could be sufficient to produce 
damage in the feeder cells that results in the same volume of signals being released 
from the feeder cells as when they are irradiated with 100 kJ m-2 UVA. 
 
X. Clonogenic survival assays demonstrated that the UVA-induced 
bystander effect is dose-dependent following 1 week co-culture 
In order to further investigate whether the UVA-induced bystander effect is dose-
dependent or not and to assess whether 25 kJ m-2 UVA was the lowest dose 
sufficient to induce the effect, clonogenic survival assays were completed using the 
previous doses and an additional dose of 12.5 kJ m-2 UVA. Bystander cells were 
fixed and stained with giemsa following one week co-culture with UVA irradiated 
cells. It was found that the number of colonies decreased with increasing UVA dose, 
suggesting that there is a dose-dependent bystander effect created by UVA (Figure 
3.11). Whiteside et al. (2011), using a similar co-culture experimental design as the 
present study, showed that UVA-irradiated feeder cells release signals for a minimum 
of three days following irradiation. Perhaps the lack of a dose-dependent effect seen 
at 48 h is due to the implemented doses of UVA releasing similar amounts of signals 
for this duration, but as the duration of the co-incubation increases, the amount of 
signals released by cells exposed to lower doses of UVA begins to decrease. As a 
result, increased co-culture duration and increased UVA exposure causes more 
signals to be received by the bystander cells with increased damage leading to the 
DDR-mediated loss of viability. This could explain the dose-dependent decrease in 
survival following one week co-incubation in comparison to 48 h. A future experiment 
could test this by irradiating the feeder cells with the same UVA doses as the present 
study and co-culturing these with nonirradiated bystander cells for 48 h. Following 
this, the inserts could be transferred to the wells of six-well plates containing 
nonirradiated bystander cells. This would allow comparison between nonirradiated 
cells which received signals released by feeder cells up to 48 h and those which 
received signals from 48 h up to 1 week. Alternative durations could be investigated 
to further investigate the dynamics of signal release from the irradiated cells. 
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Alternatively, it is possible that the composition of signals released by the irradiated 
cells varies and changes with increased incubation. As a result, it is possible that the 
dose-dependent decrease in cell survival seen following one week co-incubation is 
due to activation of a different pathway other than the DDR (Banerjee et al., 2005). 
Future research should therefore assess how the dose-dependent UVA-induced 
bystander effect changes with varying durations of co-incubation and should also 
assess both DDR initiation and clonogenic survival. If similar immunofluorescent 
techniques were to be used in future research to assess DDR activation, the optimal 
density at which bystander cells should be seeded would need to be determined in 
order to prevent issues with contact inhibition as co-culture duration increases.  
Another possible explanation as to why a dose-dependent response was observed at 
1 week could be through dose-dependent activation of alternative pathways, other 
than the DDR. This may lead to apoptosis induction and therefore decreased 
colonies at higher UVA doses.  
 
XI. Using immunofluorescence to further analyse the dose-dependent 
UVA-induced bystander effect 
As well as assessing S-phase entry in relation to co-incubation duration, UVA dose 
and its effect on bystander cell proliferation was also examined. The proportion of 
EdU positive cells increased between control bystander cells and those that were co-
cultured with UVA irradiated cells. However, the number of EdU positive bystander 
cells did not increase in a dose-dependent manner. As 25 kJ m-2 UVA was found to 
be sufficient to induce a bystander effect following 48 h co-culture, as determined by 
increased H2AX activation, it is highly probable the increased number of cells in S- 
and G2 phase is a result of the same factor as with 100 kJ m-2 UVA. It would be 
interesting to see if the number of EdU positive bystander cells decreased in a dose-
dependent manner with increased duration of co-incubation, similar to how a dose-
dependent bystander effect was observed following seven days co-incubation. Would 
there be fewer EdU positive cells as the amount of replication stress decreased? 
Additionally, the type ofH2AX signal produced was also investigated in the context 
of varying the dose of UVA to which feeder cells are exposed to. The proportion of 
pan-nuclear stained cells was slightly elevated for the bystander cells co-cultured 
with UVA irradiated cells in comparison to control bystander cells, although the 
increase was not significant. No difference was seen between the different UVA 
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doses. As mentioned above, Meyer et al. (2013) suggest that pan-nuclear staining is 
dependent on the amount of DNA damage the cell possesses. The lack of a dose-
dependent increase in the number of pan-nuclear stained cells supports the idea that 
at 48 h, the same amount of damage signals are released from the feeder cells, 
regardless of the UVA dose to which they were exposed.  
Although the present study provides some insight into the UVA-induced bystander 
effect in terms of how H2AX phosphorylation changes over time, how various UVA 
doses affect the bystander effect and how cell cycle progression is impacted, the 
data do not provide any further insight into the source of the lesions in the bystander 
cells. This is important as the DDR is initiated following detection of different types of 
lesions and H2AX activation is common to numerous arms of the DDR.  
In 2014, Widel et al. investigated the roles of ROS and interleukins in the UVA-
induced bystander effect. Here, they found increased levels of ROS and IL-6 within 
the bystander cells and within the media of the irradiated cells, suggesting that these 
may be the signals released from the irradiated cells. Remond et al. (2014) 
supported the suggestion for the involvement of ROS in the UVA-induced bystander 
effect when investigating the interplay in the bystander effect between different cell 
types. Steel (2016) used antioxidants to investigate the role of ROS in the UVA-
induced bystander effect and found that the number of EdU positive cells was 
reduced. Future research should be conducted to investigate the role of other factors, 
such as IL-6, in increasing the number of EdU positive cells, as they may also have 
an effect.  
IL-6 inhibitors should also be investigated in the context of the UVA-induced 
bystander effect to investigate the findings of Widel et al. (2014) further. There is an 
abundance of evidence that ROS generation following direct UVA exposure occurs 
via type I and II photosensitisation reactions. Although it is likely that ROS generated 
via the UVA-induced bystander effect occurs through this mechanism, there is some 
evidence for the involvement of dermal extracellular matrix proteins such as keratin, 
collagen and elastin (Wondrak et al. 2003). Another possible avenue for future 
research when investigating the source of the lesions in the bystander cells is to 
investigate the mechanism by which the released ROS induce their damaging 
outcomes in the bystander cells. 
An important aspect that needs to be considered when investigating the radiation-
induced bystander effect is that the skin is a complex organ harbouring a rich array of 
different cell types, which together carry out a number of diverse functions including 
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protection from insults, infection and dehydration and also enabling thermoregulation 
and sensory perception. It is therefore important to consider how one cell type that 
received direct irradiation, whether it is due to UVA or not, and how it exerts a 
bystander effect to nearby cells that are the same type as itself, but also that are 
different. For example, does the UVA-induced bystander effect produce a different 
outcome when signals are released from keratinocytes and taken up by melanocytes 
than when signals are received by keratinocytes following their release from a UVA-
irradiated fibroblast?  
Redmond et al. (2014) investigated this in vitro using a co-culture model similar to 
that in the present study. The UVA-induced bystander effect was observed between 
all three cutaneous cell types (melanocytes, keratinocytes and fibroblasts). The 
significant finding was that melanocytes appeared to be more resistant to direct UVA 
effects compared to the other cell types studied and that melanocytes were more 
susceptible to bystander oxidative signalling. CPDs have been demonstrated as 
being the predominant lesions generated following direct UVA irradiation. In many 
cell types, CPDs occur at rates of approximately 5-fold higher than 8-oxoG, the main 
lesion generated from oxidative damage. Interestingly, however, when comparing the 
ratio of CPDs to 8-oxoG in melanocytes, Mouret et al. (2012) found that the ratio 
decreased to 1.4 in melanocytes. Together, these studies suggest that melanocytes 
are more susceptible to oxidative damage. UVA is able to penetrate deeper into the 
skin than UVB, which is rapidly attenuated with increasing depth. UVA lesion 
generation has been found to increase with increasing skin depth (Tewari et al. 
2013). Consequently, the role of the UVA-induced bystander effect in 
melanomagenesis needs to be considered. Deciphering the role of UVA in 
melanomagenesis would have huge clinical implications and would help shed light on 
conflicting arguments within the literature in regards to whether UVA can or cannot 
induce melanomagenesis (Noonan et al., 2012, De Fabo et al., 2004). One method 
by which this could be analysed could be to implement next-generation sequencing 
to compare the mutation spectra between cells directly irradiated with UVA and 
bystander cells co-cultured with UVA exposed cells.  
Additionally, investigations into the UVA-induced bystander effect use two chamber 
models to investigate how co-culturing differentially treated cell populations affects 
nonirradiated bystander cells. However, this only takes into account signalling that 
occurs through a permeable membrane that separates the two populations and does 
not consider signalling through intercellular connections such as gap junctions. In 
vivo, not every cell will absorb UVA and other forms of irradiation directly and so the 
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signals released through intercellular connections to neighbouring cells also need to 
be considered in addition to signals released and taken up by cells that are not in 
direct contact with the directly irradiated cell. A number of studies have considered 
the involvement of gap junctions in the radiation-induced bystander effect using 
methods that involve inhibition of gap junction intercellular communication, with 
mixed results observed for different types of radiation (Gerashchenko and Howell, 
2003, Azzam et al., 1998, Mothersill and Seymour, 1998). 
 
XII. Future work 
In addition to the suggestions made in regards to future work for specific areas 
involving the outcomes of UVA irradiation (e.g. the UVA-induced bystander effect), a 
number of other general areas of research could possibly be explored in future 
research into UVA and the DDR. Firstly, the DDR components investigated in the 
present study are limited as, at most, only H2AX and p-Chk2 activation were 
analysed. It would therefore make sense to analyse how activation of other 
components within the different pathways of the DDR change following both direct 
and indirect UVA irradiation, and how inhibition of various DNA damage sensors and 
kinases such as ATM and ATR impact these. For example, p53-binding protein 1 
(53BP1) can be phosphorylated by ATM and together with mediator of DNA damage 
checkpoint 1 (MDC1) forms a positive feedback loop to enhance ATM activation and 
result in sustained DDR signalling (Lou et al., 2003). There is evidence for the 
accumulation of 53BP1 to sites of DNA damage and H2AX foci formation (Stixova et 
al., 2014). In the present study, p-Chk2 activation did not change following ATM 
inhibition. Therefore, it would be interesting to see how 53BP1 activation and 
accumulation is affected by similar levels of ATM inhibition and to also assess if MRN 
complex inhibition affects 53BP1 activation differently. Additionally, activation of DDR 
components that are downstream of ATR should also be investigated in the context 
of both direct and indirect UVA exposure and both in the absence and presence of 
DDR component inhibitors. In particular, p-Chk1 activation should be assessed at 
various times following direct UVA irradiation in the absence of any inhibition and 
following individual and combined inhibition of ATM, MRN and ATR.  
The methods used in the present study to investigate the role of UVA on DDR 
initiation failed to provide any insight into how different lesions generated by direct 
and indirect UVA irradiation activated the different pathways within the DDR. Whilst 
UVA irradiation resulted in increased H2AX activation, this can occur via H2AX 
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phosphorylation by either ATM or ATR. ATM inhibition caused decreased H2AX 
activation but activation levels remained above basal levels present in untreated 
cells. Although it is possible that DSBs generated by UVA resulted in the generation 
of ssDNA regions available for detection by RPA and the 9-1-1 complex, the 
available data only allows for speculation based on previous research. Activation of 
the DDR and its various components, including how their activation changes over 
time should be investigated alongside investigations assessing the different types of 
DNA lesion generated. In particular, how does inhibition of various components 
impact the spectra of generated lesions? Due to the fact that ATM, ATR and DNA-
PKcs have been implemented as being involved in the repair of DNA lesions 
generated following UVA exposure, it would be interesting to see how the use of a 
pan-PIKK inhibitor impacted DDR component activation and how this was reflected in 
the types of lesion generated and the resulting mutational spectrum.  
As mentioned previously, skin is composed of a diverse array of cell types including 
keratinocytes, melanocytes and fibroblasts. The consequences of direct and indirect 
UVA exposure on DDR initiation, cell viability and the types of lesions generated 
need to be investigated in the context of models that reflect human skin. Additionally, 
whilst terrestrial UVR to which we are exposed to consist of 90-95% UVA, a small 
proportion of this still consists of UVB. As a result, the cooperative role of UVB and 
UVA on the DNA damage response needs to be considered. Both wavebands, 
regardless of the proportion of terrestrial UVR they make up, are able to produce 
DNA damage and contribute to mutagenesis and carcinogenesis. This is of particular 
importance in relation to malignant melanoma, which, due to its high potential for 
metastasis, is the most dangerous form of skin cancer. 
At present, very little is known about the comparative action of UVA and UVB 
irradiation on the DNA damage response in melanocytes, with the available literature 
consisting of only one paper to date describing H2AX activation using a UV source 
consisting of non-terrestrial ratios of UVA to UVB (Swope et al., 2014). 
Understanding how melanocytes respond to DNA damage caused by 
environmentally relevant doses of UVA and UVB may provide important insight into 
understanding the underlying process of UV carcinogenesis. Not only should the 
comparative role of direct irradiation with UVB and UVA on the DDR of melanocytes 
be investigated but the difference in DDR activation between primary melanocytes 
from both light skinned and dark skinned neonates should also be considered, given 
the important role that melanin plays. Also, the comparative role of UVA and UVB on 
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DDR activation in bystander melanocytes as a result of signals received from cells of 
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